0% found this document useful (0 votes)
10 views

MCAT Biochem Notes

The document provides an extensive overview of biochemistry topics, focusing on amino acids, peptides, proteins, and enzymes. It details the structure, classification, and properties of amino acids, peptide bond formation, protein structures, and enzyme mechanisms. Key concepts include the roles of essential and nonessential amino acids, the significance of tertiary and quaternary structures, and the catalytic functions of various enzyme classes.

Uploaded by

King
Copyright
© © All Rights Reserved
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
10 views

MCAT Biochem Notes

The document provides an extensive overview of biochemistry topics, focusing on amino acids, peptides, proteins, and enzymes. It details the structure, classification, and properties of amino acids, peptide bond formation, protein structures, and enzyme mechanisms. Key concepts include the roles of essential and nonessential amino acids, the significance of tertiary and quaternary structures, and the catalytic functions of various enzyme classes.

Uploaded by

King
Copyright
© © All Rights Reserved
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 54

MCAT Biochemistry

1. Amino Acids, Peptides, Proteins


1.1. Proteinogenic Amino Acids
● AAs: amino, carboxy (CA) groups
○ In some AAs, amino and CA groups aren’t bonded to same C (e.g., GABA, with amino group on gamma C)
○ Proteinogenic AAs: 20 α-AAs encoded by codons in humans
○ Essential AAs: can’t be biosynthesized or can’t made by the body to meet demand. 9 in number.
■ “Very Heavy MILK WTF”: Val, His, Met, Iso, Leu, Lys, Trp, Thr, Phe
○ Nonessential AAs: can be biosynthesized or made by the body to meet demand.
■ “DEANS”: Asp, Glu, Ala, Asn, Ser
● Stereochemistry: all AAs are chiral, (S), ʟ-isomers
○ Except Gly, which is achiral b/c its side chain is H
○ Except Cys, which is (R) b/c ⦚–CH2SH > ⦚–COOH in priority order
● Hydrophobicity
○ Hydrophobic: nonpolar, hydrocarbon side chains (VALIF: Val, Ala, Leu, Iso, Phe)
■ Likely to be found in the interior of proteins, away from water on the surface of the protein
○ Hydrophilic: polar/charged AAs (Ser, Thr, Gln, Asn, Glu, Asp, Lys, Arg, His)
● Side-chain structure
○ Nonpolar, nonaromatic (GAVLIMP)
■ Glycine (Gly, G) ⦚–H
■ Alanine (Ala, A) ⦚–Me
■ Valine (Val, V) ⦚–iPr
■ Leucine (Leu, L) ⦚–CH2–iPr
■ Isoleucine (Iso, I) ⦚–CHMeEt
■ Methionine (Met, M) ⦚–CH2–CH2–SMe
● SMe and not SH, so nonpolar
● One of two aas with sulfur
■ Proline (Pro, P) ⦚–[pyrrolidine] (NH adj. to branch)
● Has a cyclic structure in the side chain
● Rigid ring, affects 2° structure i.e., makes kinks in alpha helices
○ Aromatic (FYW)
■ Tyrosine (Tyr, Y) ⦚–CH2–PhOH (para)
● Somewhat polar
● Hydroxyl is target for phosphorylation in post-transcriptional modification
■ Phenylalanine (Phe, F) ⦚–CH2Ph
■ Tryptophan (Trp, W) ⦚–CH2–[indole] (double bond of 5-membered ring adj. to branch)
● Precursor to serotonin, melatonin, and vitamin B3
○ Polar (STQNC)
■ Serine (Ser, S) ⦚–CH2OH
● Hydroxyl is highly polar, H-bonding
● Hydroxyl is target for phosphorylation in post-transcriptional modification
■ Threonine (Thr, T) ⦚–CH(Me)OH
● Hydroxyl is less polar than in Ser (due to Me), H-bonding
● Hydroxyl is target for phosphorylation in post-transcriptional modification
■ Cysteine (Cys, C) ⦚–CH2SH
● Can form disulfide linkages, with one of two aas with sulfur
● Has a thiol side chain which is less polar than hydroxyls in Ser/Thr (S is less EN than O)
● Thiol can be oxidized
■ Asparagine (Asn, N) ⦚–CH2–CONH2
● Also negatively charged
● Amide can’t be deprotonated
■ Glutamine (Gln, Q) ⦚–CH2–CH2–CONH2
● Also negatively charged
● Amide can’t be deprotonated
○ Acidic, (–) charged (DE)
■ Aspartate (Asp, D) ⦚–CH2–COO–
● CA is acidic
■ Glutamate (Glu, E) ⦚–CH2–CH2–COO–
● CA is less acidic than in Asp (extra alkyl is EDG)
○ Basic, (+) charged (HKR)
■ Lysine (Lys, K) ⦚–CH2–CH2–CH2–CH2NH3+
● Target for methylation and acetylation
■ Arginine (Arg, R) ⦚–CH2–CH2–CH2–NH–C(NH2)2+
● Protonating imine delocalizes (+) throughout all 3 N’s
■ Histidine (His, H) ⦚–CH2–[imidazole]+ (NH, double bond adj. to branch)
● Has a pKa near that of physiological pH
● Only imine is protonated at physiological pH (results in resonance)
1.2. Amino Acid Acid–Base
● Amphoteric: basic amino, acidic CA groups
○ Protonated (addition of a proton (H+)) in acidic soln. (low pH), deprotonated in basic soln. (high pH)
■ pH < pKa: most is protonated
■ pH = pKa: half of molecules are deprotonated, [HA] = [A–]
■ pH > pKa: most is deprotonated
○ (+)-charged in acidic soln.: ⦚–NH3+, ⦚–COOH
■ pKa of CA group ≈ 2
○ Zwitterion in neutral soln.: ⦚–NH3+, ⦚–COO–
■ (+)/(–), but electrically neutral
○ (–)-charged in basic soln.: ⦚–NH2, ⦚–COO–
■ pKa of amino group ≈ 9–10
● Titration
○ ⦚–COOH is more acidic than ⦚–NH3+
○ Add 0.5 equiv. base to acidic AA: buffer (pH = pKa, 1), flat curve
○ Add 1 equiv. base to acidic AA: all AAs are zwitterions, isoelectric point reached
■ pIacidic R = ½ (pKa, COOH + pKa, R) ≪ 6
■ pIneutral R = ½ (pKa, COOH + pKa, +NH3) ≈ 6
■ pIbasic R = ½ (pKa, R + pKa, +NH3) ≫ 6
○ Add 1.5 equiv. base to acidic AA: buffer (pH = pKa, 2), flat curve
○ NB = Isoelectric point of a peptide is the pH at which it net charge is 0
1.3. Peptide Bond Formation, Hydrolysis
● Peptides: multiple AAs/residues
○ Di/tripeptide: 2, 3 AAs
○ Oligopeptides: ≤ 20 AAs
○ Polypeptides: > 20 Aas
○ NB = These residues are joined together through peptide bonds (formed b/w -COO-group of AA and NH3+ of another AA
● Formation: ⦚–COO– + +H3N–⦚ ⇌ ⦚–CONH–⦚ + H2O
○ Condensation/dehydration, acyl substitution
■ Peptide bonds formation is a condensation/dehydration rxn that results in H20 removal
○ Partial double-bond character in C–N bond: delocalized π e– in carbonyl, amino N:
■ [⦚–(O=)C(–NH)–⦚] ↔ [⦚–(–O–)C(=N+H)–⦚]
■ Restricts rotation, rigid backbone
■ Other σ bonds are free to rotate
○ N-terminus (free amino end), C-terminus (free CA end)
■ Proteins are synthesized N to C
● Hydrolysis: reverse rxn. i.e., breaks peptide bond, consumes water
○ Hydrolytic enzymes are AA-/terminus-specific
● NB = 1. Net charge of a peptide/protein = sum of charges of its side chains and the charges of the N- and C-termini
2. At physiological pH, the N-terminus is + charged and the C-terminus is - charged, and the two charges cancel, leaving
only the side chain charge
3. Number of possible arrangements for peptide = n! where n is the number of AAs in the peptide
Examples: dipeptide 2! =2 (2x1); tripeptide 3! = 6 (3x2x1); tetrapeptide 4! = 24 (4x3x2x1)
1.4. Primary, Secondary Structure
● 1° structure: AA sequence, from N- to C-terminus
○ Covalent peptide bonds between adjacent AAs
○ Protein sequencing
● 2° structure: backbone interactions
○ H-bonding between backbone groups (carbonyl O, amide H); E.g., of 2° structure: α helix & β-pleated sheet
○ α helix: clockwise spiral
■ H-bonding 4 residues apart
■ Side chains point out from the helix
■ Pro: starts of α helices (rigid) or introduce a kink in the peptide chain when found int the middle of α helix
■ Gly: turns in α helices (conformationally flexible)
■ α helix is an important structure of keratin
○ β-pleated sheet: rippled sheet
■ Anti/parallel H-bonding peptide chains
■ Pro: turns in β-pleated sheets
■ Fibroin, primary protein component of silk fibers, is composed of β-pleated sheet.
1.5. Tertiary, Quaternary Structure
● Fibrous (sheets/long strands), globular (spherical) proteins
● 3° structure: Three-dimensional shape; side-chain interactions
○ Hydrophobic/philic interactions between side chains
■ Hydrophobic AAs inward, hydrophilic AAs outward
● Hydrophobic AAs outside: ΔH > 0 (break H bonds w/in water), ΔS < 0 (no solvation layer) → ΔG > 0
(nonspontaneous)
● Hydrophobic AAs inside: ΔS > 0 (solvation layer, more configurations for water) → ΔG < 0
(spontaneous)
○ Salt bridges: acid–base rxns., ionic bonds
○ Disulfide bonds: S–S, forms loops in peptide chain in oxidizing environment
■ Cys + Cys → cystine + 2 H+ + 2 e– (oxidation)
■ This bind can be broken by reducing agents such as β-mercaptoethanol or dithiothreitol
○ Molten globule: 3° structure formed
○ Denaturation: loss of 3° structure
○ Non-covalent interactions, such as hydrogen bonds, ionic bonding, and hydrophobic effects, allow proteins to fold into 2o
structures (α-helices and β-sheets) that combine to form tertiary structures.

● 4° structure: multiple subunits


○ Subunits: smaller globular proteins, e.g., hemoglobin and IgG antibodies
○ Allostery: conformational/structural change in 1 subunit can change other subunits’ activity
○ Reduce protein SA, reduce amt. DNA needed to encode protein, bring catalytic sites closer
○ Conjugated proteins: prosthetic groups (organic molecules, metal ions, etc.) covalently bonded to protein
■ Lipoproteins (lipids), glycoproteins (carbs), nucleoproteins (NAs)
○ NB = All proteins have elements of 1o, 2o, 3o; not all proteins have 4o structure
1.6. Denaturation
● Temperature ↑ = average KE ↑ can overcome hydrophobic interactions
● Solutes can break disulfide bridges (reduction), overcome H bonds
● Detergents can disrupt noncovalent bonds, solubilize proteins
● NB = Proteins lose functionality when their 3o structure unfolds (denaturation)

2. Enzymes
2.1. Biological Catalysis
● Catalysts
○ Change kinetics: Ea ↓, easier to form/more stable transition state (TS ‡), rxn. rate ↑
○ Thermodynamics of rxn. (ΔHrxn, Keq, ΔG) stay the same
■ However, Ea ↓ means optimal temp may be lower (less energy needed to reach Ea)
○ Not changed or consumed in rxn.
○ Sensitive to pH, temp
● Major classifications: “LIL HOT”
○ Ligases: responsible for joining or additions/syntheses between large, similar molecules
■ Require ATP
■ e.g., DNA ligase
○ Isomerases: rearrange bonds w/in molecule
■ Constitutional isomers, stereoisomers
■ e.g., phosphoglucose isomerase, TPI, aconitase, mutases
○ Lyases: cleavage of 1 molecule into 2 molecules
■ No hydrolysis (without H2O), no redox (without transfer of electrons)
■ e.g., synthases, decarboxylases, aldolases
● synthases catalyze the synthesis of 2 molecules into a single molecule
○ Hydrolases: catalyze the breaking of a compound into 2 molecules using addition of H2O (hydrolysis)
■ e.g., phosphatase, lipases, peptidases, nucleases
○ Oxidoreductases: catalyze oxidation-reduction (redox) rxn that involves the transfer of electrons
■ Has e–-carrier cofactors, like NAD+ or NADP+
■ Reductants (e– donors), oxidants (e– acceptors)
■ e.g., dehydrogenases, reductases, oxidases
● Dehydrogenation rxn involves the removal of hydrogen to form a double bond
○ Transferases: move functional groups between molecules
■ Kinases: transfer phosphate group (Pi) generally from ATP to another molecule
● NB = Enzymes lower the activation energy; enzymes do not alter the free energy (ΔG) or enthalpy (ΔH), rather they change the
rate (kinetics) at which equilibrium is reached.
2.2. Mechanisms
● Enzymes provide favorable microenvironments (pH, charge), stabilize TS‡, bring reactive groups closer together
● Enzyme–substrate binding
○ Enzymes posses an active site where catalysis occur and act on a molecule known as substrate
○ Substrate binds to active site, forms enzyme–substrate complex (ESC)
■ H bonding, ionic interactions, transient covalent bonds stabilize binding
○ Lock-and-key theory: substrate fits in active site w/ no conformational changes
○ Induced-fit model: upon binding, active site changes conformation to complement substrate
■ More accepted
● Cofactors/coenzymes: nonprotein molecules needed for effective activity
○ Cofactors (inorganic/metal): minerals, etc.
○ Coenzymes (organic): vitamins, vitamin derivatives
■ Water-soluble vitamins: easily excreted, must be replenished regularly
● B vitamins ("The RhiNo Paid Pill Boy For Coke")
○ B1: thiamine (TPP)
○ B2: riboflavin (FAD, FMN)
○ B3: niacin (NAD)
○ B5: pantothenate (CoA)
○ B6: pyridoxine
○ B7: biotin
○ B9: folate
○ B12: cobalamin
● C: ascorbate
■ Fat-soluble vitamins (ADEK): regulated by partition coefficients (non/polar solubilities)
● A: β-carotene, retinol/al/oic acid
● D: cholecalciferol, etc.
● E: tocopherols, tocotrienols
● K: phylloquinone, menaquinones
○ Apoenzymes (w/o cofactors), holoenzymes (w/ cofactors)
○ Prosthetic groups (tightly bound), cosubstrates (loosely bound)
2.3. Kinetics
● Enzyme activity = velocity = rate
● Saturation: enzyme at max velocity (vmax, mol enzyme/s), need more enzyme to speed up rxn.
○ i.e., as substrate concentration increases, the rxn rate increases until a maximum value is reached
○ Enzyme kinetics is dependent on: environmental condition, conc. of substrate and enzyme
● Michaelis–Menten (MM) kinetics
○ As the amount of substrate increases, the enzyme is able to increase its rate of reaction until it reaches a maximum
enzymatic reaction rate (vmax).
■ NB = Once vmax is reached, adding more substrate will not increase the rate of rxn.
○ MM equation: E + S ⥫(k1/k–1)⥬ ES ⤚(kcat)→ E + P
■ MM equation describes how the rate of the reaction, v, depends on the concentration of both the enzyme, [E], and
the substrate, [S], which forms product, [P].
○ Assumptions
■ In E + S ⇌ ES (⇌ EP →) E + P, rate-limiting step is ES ⇌ EP
■ [S] ≫ [E], [P]0 ≈ 0
■ d[E]/dt, d[S]/dt, d[ES]/dt are negligible
○ Michaelis constant (Km): enzyme affinity for substrate, intrinsic to enzyme/substrate
■ Km = [S] when v = ½ vmax (when 50% of enzyme is bound as ES)
● [S] < Km: changing [S] greatly changes v
● [S] > Km: changing [S] has little effect on v
■ Km = [E][S]/[ES] at steady state, Km = (kcat + k–1) / k1
● Different from binding constant: KD = [E][S]/[ES] at equilibrium, KD = k–1/k1
■ Comparing enzymes/substrates
● Low Km: high substrate affinity (less S needed for 50% saturation = faster v for given [S])
● High Km: low substrate affinity (more S needed for 50% saturation = slower v for given [S])
○ kcat: rate of ES → P i.e., the rate at which an enzyme bound substrate is converted to product
■ Low kcat (or low plateau): low turnover, slower rxn
■ High kcat (or high plateau: high turnover, faster rxn
■ NB = On the MM plot, catalytic turnover is reflected in the height of the plateau that occurs at high substrate conc.
■ Catalytic efficiency = kcat / Km is a measure if enzyme specificity
○ vmax = [E]0kcat
○ v = d[P]/dt = vmax[S] / (Km + [S])
■ v ≈ (kcat / Km) [E][S] when Km ≫ [S]
● MM plot: v vs. [S], hyperbolic
○ Plotting: (0, 0), (Km, ½ vmax), (∞, vmax)

● Lineweaver–Burk (LB) plot: 1/v vs. 1/[S], linear


○ Double reciprocal of MM plot
○ Plotting: intercept of line on x axis = –1/Km, and intercept of line on y axis = 1/vmax (–1/Km, 0), (0, 1/vmax), slope = Km /vmax
○ Used to calculate Km, vmax
○ NB = LB plot is useful when determining the type of inhibition that an enzyme is experiencing

● Cooperativity
○ v vs. [S] graph is sigmoidal
○ Cooperative enzymes have multiple subunits, multiple active sites
○ Low-affinity tense state (T), high-affinity relaxed state (R)
■ More substrate bound: (R) favored
■ Less substrate bound: (T) favored
○ Hill’s coefficient (n): measures cooperativity
■ n > 1: (+) cooperative binding, more ligands bind → enzyme affinity ↑
■ n = 1: no cooperativity
■ n < 1: (–) cooperative binding, more ligands bind → enzyme affinity ↓

2.4. Effects of Local Conditions on Activity


● Temp: usually, v doubles every +10 °C until optimal temp = 37 °C
○ Beyond optimal temp, v plummets: enzyme denatures
● pH: highest v at optimal pH = 7.4
○ Except in digestive tract: pepsin in stomach (optimal pH ≈ 2), pancreatic enzymes in duodenum (optimal
pH ≈ 8.5)
● Salinity: [salt] ↑ → v ↓
○ Salt disrupts H bonds/ionic interactions, partially changes enzyme conformation or denatures enzyme
2.5. Regulation
● Feedback regulation
○ (–) feedback: high [product] of pathway inhibits enzyme(s) upstream, avoid producing too much product
○ Feedforward regulation: preceding intermediates regulate enzyme
● Reversible inhibition
○ Competitive: inhibitor binds active site, competes w/ substrate
■ Km ↑ (more [S] needed for 50% saturation), no change in vmax (high enough [S] can outcompete inhibitor)
● Overcome by increasing [S] to outcompete inhibitor

■ LB plot: x-int. is smaller, lines intersect at y-axis


○ Noncompetitive: inhibitor binds allosteric site, changes enzyme conformation; binds with equal affinity to enzyme and ESC
■ No change in Km (affinity of uninhibited enzyme is the same), vmax ↓ (less enzyme available)
● Can’t overcome by increasing [S], since Km is unchanged
■ Inhibits E, ES equally

■ LB plot: y-int. is larger, lines intersect at x-axis


○ Mixed: noncompetitive, but diff. affinities for E, ES
■ Do not bind at the active site, but at an allosteric site
■ Km ↑ if inhibiting E is preferred, Km ↓ if inhibiting ES is preferred, vmax ↓
■ LB plot: lines intersect at point not on axes
○ Uncompetitive: inhibitor binds allosteric site of ES only
■ Km ↓ (removing ES from system drives Le Châtelier), vmax ↓ (less ES available)
■ LB plot: lines are parallel
● Irreversible inhibition
○ Inhibitor disables active site for a long time, or permanently
○ Overcome only by increasing [E]
● Regulated enzymes
○ Allosteric: activators/inhibitors bind allosteric sites
○ Covalently modified
■ Phosphorylation (covalent modification with phosphate): activate/deactivate enzyme
■ Glycosylation (covalent modification with carbohydrate): tag enzyme for transport, modify activity/selectivity
○ Zymogens: secreted in an inactive form and have regulatory domain must be cleaved/modified to activate enzyme
■ e.g., trypsinogen (inactive form) – trypsin (active form) involved in digestion, another e.g., caspases (apoptosis)

3. Nonenzymatic Protein Function


3.1. Cellular Functions
● Structural proteins: cytoskeleton/extracellular matrix (ECM), highly repetitive 2°/super-2° structure, and are fibrous in nature
○ Collagen: most of ECM. They provide strength, and flexibility
■ Most common protein in the body
■ Trihelical fibers characteristics: 3 left-handed helices woven into super-2° right-handed helix
● High Gly content (unusual for α helices), b/c structure packs AAs very close together
○ Elastin: stretch/recoil in skin, lungs, endothelia, etc.
■ Mostly A/G/V/P AAs
○ Keratin: intermediate filaments, cell mechanical integrity, regulation
■ Only in epithelia, most of hair and nails
■ α helices
○ Actin: microfilaments, thin filaments in sarcomeres, cell migration
■ Polarity: (+) away from, (–) toward nucleus
● Allows unidirectional movement along filament
■ Double helices
■ It is the most abundant protein in eukaryotic cells
○ Tubulin: microtubules, structure, segregate chromosomes in anaphase, intracellular transport, cell migration/motility
■ Polarity: (+) away from, (–) toward nucleus
■ 9+2 structure (9 doublet tubles, 2 central tubles) in flagella, 9 triplets in centrioles
● Motor proteins
○ Myosin: primary motor protein that interacts with actin and is involved in motor activity, and cellular transport
■ 1 head: neck movement = power stroke of sarcomere contraction
○ Kinesin: aligns chromosomes in metaphase, depolymerizes microtubules in anaphase
■ 2 heads: move in “steps,” 1 or both heads attached at all times
● ATP on attached head rotates kinesin → other head attaches when its ADP is removed →
original head detaches when its ATP is dephosphorylated
■ Vesicle transport: move toward (+) (away from nucleus), anterograde
○ Dynein: involved in cilia and flagella sliding movement (cell migration)
■ Vesicle transport: move toward (–) (toward nucleus), retrograde
● Binding proteins: bind and sequester/transport molecules
○ Sequester: high affinity for substrate
○ Transport: varying affinity depending on environment
○ e.g., hemoglobin, Ca2+-binding proteins, transcription factors
● Cell adhesion molecules (CAMs): are integral membrane proteins and helps cells to bind cell to ECM/other cells
○ Cadherins (Ca2+-dependent adhesion proteins): glycoproteins, mediate Ca2+-dependent cell adhesion
■ Hold similar cell types together
○ Integrins: bind cell to/communicate w/ ECM, cell signaling
■ Have two membrane-spanning α, and β chains
○ Selectins: allow cells to bind membrane carbohydrates, recruit cytokines/inflammation factors, allow WBC migration
■ On WBCs, blood vessel epithelia
● Antibodies/immunoglobulins (Ig’s)
○ 2 identical heavy chains, 2 identical light chains, held together by disulfide bonds and noncovalent interactions
○ Variable, diversity (in heavy chains), joining, constant regions
■ Antigen-binding region: V(D)J

○ Functions
■ Neutralization: block pathogen or toxin surface
■ Opsonization: mark pathogen for phagocytosis
■ Agglutination: clump antigens/antibodies into large insoluble protein complexes for phagocytosis
3.2. Biosignaling
● Ion channels: specific pathways for facilitated diffusion of ions
○ Ungated: unregulated and always open
■ e.g., K+ leak channels in all cells
○ Voltage-gated: regulated by Δ membrane potential near channel
■ e.g., V-gated Na+ channels in excitable cells, pacemaker channels in sinoatrial node
○ Ligand-gated: regulated by ligand-binding
■ e.g., GABAA receptors (ligand-gated Cl– channels) at postsynaptic membranes
● Enzyme-linked receptors: receptors that catalyze rxns. after binding ligand and usually initiates a 2 nd messenger cascade
○ Membrane-spanning domain: anchors receptor in membrane
○ Ligand-binding domain: binds ligand, induces conformational change, activates catalytic domain
○ Catalytic domain: often starts 2nd messenger cascade
● G protein-coupled receptors (GPCRs): signal transduction
○ Heterotrimeric G protein (a, b, g)
■ 7 membrane-spanning α helices
○ G-protein families
■ Gs: stimulates adenylyl cyclase, [cAMP] ↑
■ Gi: inhibits adenylyl cyclase, [cAMP] ↓
■ Gq: activates phospholipase C, cleaves PIP2 (phospholipid) from membrane, cleaves PIP2 into DAG + IP3
● IP3: opens Ca2+ channels in ER, [Ca2+] ↑
○ Trimeric G-protein cycle
■ Inactive G protein: α (w/ GDP), β/γ subunits
■ Ligand binds GPCR → receptor activated → α GDP is phosphorylated, activated α dissociates from β/γ
■ Activated α regulates adenylyl cyclase activity
■ Dephosphorylated α rebinds to β/γ, G protein inactivated
3.3. Protein Isolation
● Homogenize then centrifuge cell/tissue to isolate proteins by mass
● Electrophoresis
○ Put sample in electric field thru medium
○ Negatively charged compounds or anions migrate to positively charged anode, while positively charged compounds or
cations migrate to negatively charged cathode
○ For proteins and small molecules, the gel is polyacrylamide. For larger molecules (>500 bp), the gel is agarose
■ Migration velocity: v = Ez/f, where E = electric field, z = molecule net charge, f = frictional coefficient
■ Anode is (+), cathode is (–) b/c gel electrophoresis is an electrolytic cell (nonspontaneous)
○ Porous matrix medium
■ Small, highly charged molecules in large E = faster migration
■ Large, convoluted, neutral molecules in small E = slower migration
○ Native PAGE (polyacrylamide gel electrophoresis): proteins in native states (original structure) or non-denaturing
conditions
■ Can’t differentiate proteins w/ same mass:charge, mass:size ratios
■ Compares proteins of known similar mass by size, charge
● In other words, they are used to separate proteins based on charge and size
○ SDS-PAGE: PAGE method in denaturing condition where the detergent SDS (sodium dodecyl sulfate) is used
■ SDS disrupts all noncovalent interactions, binds proteins
● Denatures proteins, and erases original charge (i.e., gives them a uniform charge)
■ Separates proteins by size (i.e., molecular weight or mass only)
● Only E and f (∝ mass) affect v
○ Reducing SDS-PAGE: Exactly the same as SDS-PAGE, but with the addition of a reducing agent, b-mercaptoethanol,
which will reduce the disulfide bridges and result in a completely denatured protein
○ Isoelectric focusing: a gel electrophoresis method that separates protein on the basis of their relative contents of acidic
and basic residues (i.e., their isoelectric point)
■ basic at cathode, acidic at anode
■ When protein reaches region where pH = pI, protein becomes neutral, stops migrating
■ Separates proteins by pI only
■ Can run from either end
● Southern blotting: detection of a specific DNA sequence in a sample
● Northern blotting: detection of a specific RNA sequence in a sample
● Western blotting: detection of a specific protein in a sample
● Chromatography: separates protein mixtures on the basis of their affinity for a stationary phase or a mobile phase
○ Place sample on stationary phase/adsorbent (solid), run it w/ mobile phase/eluent (liquid)
○ Sample elutes, migrates at diff. speeds, partitions
■ High affinity for stationary phase: slow migration, high retention time
■ High affinity for mobile phase: fast migration, low retention time
○ Column chromatography: elute sample thru column filled w/ silica/alumina beads, using gravity. That is uses beads of
polar compound, like silica or alumina (stationary phase), with a nonpolar solvent (mobile phase)
■ the less polar the compound, the faster it can elute through the column (short retention time)
○ Ion-exchange chromatography: charged beads, retains oppositely charged proteins. For instance, a + charge column will
attract and hold a + charge protein as it passes through the column
■ Elute retained proteins w/ salt gradient
○ Size-exclusion chromatography: uses porous beads. Smaller proteins become trapped and elute slower, while large
proteins are not trapped and elute first
○ Affinity chromatography: beads coated with receptors or targets or antibodies, and retain specific proteins
■ Elute retained proteins w/ free receptors/targets/antibodies
3.4. Protein Analysis
● Structure
○ X-ray crystallography: isolate, crystallize protein, then measure e– densities thru X-ray diffraction pattern
■ In other words, the protein structure can be primarily determined through x-ray crystallography
○ Nuclear magnetic resonance (NMR) spectroscopy, can also be used
● Amino-acid sequence
○ Edman degradation: sequentially remove N-terminus AA, analyze w/ mass spec
■ Only for small proteins (≤ 70 AAs)
○ Proteases: cleave protein at specific AAs, analyze smaller fragments w/ electrophoresis or Edman degradation
■ For large proteins
■ Breaks disulfide links, salt bridges
● Activity
○ Monitor known rxn. w/ given [S], compare rate to a standard
● Concentration
○ Protein concentration is determined calorimetrically, either by UV spectroscopy, or through color change rxns (such as
bicinchoninic acid (BCA) assay, Lowry reagent assay, and Bradford protein assay)
■ Bradford protein assay
● Mix protein w/ Coomassie Brilliant Blue dye (protonated, green-brown)
● Dye deprotonates on binding, turns blue
● [blue dye] ↑ = [protein] ↑
● Most used, but valid only for samples w/ 1 protein

4. Carbohydrates
4.1. Classification
● General formula: Cn(H2O)m
● Monosaccharides
○ Trioses (3 carbons), tetroses (4 carbons), pentoses (5 carbons), hexoses (6 carbons), etc.
○ Aldoses: have aldehyde as their most oxidized group
■ Simplest aldose: glyceraldehyde, CHO–(H)C(OH)–CH2OH
● The carbonyl carbon is the most oxidized and has the lowest possible number
● In an aldose, the aldehyde carbon will always be carbon number one (C-1)

○ Ketoses: have ketone as their most oxidized group


■ Simplest ketose: dihydroxyacetone, CH2OH–CO–CH2OH
● The carbonyl carbon is the most oxidized; the lowest number it can be assigned is carbon number 2 (C-2)
○ Ketoses can also participate in glycosidic bonds at this carbon C-2

○ Common sugars: fructose, glucose, galactose, mannose

● Stereochemistry
○ Optical/stereoisomers: same connectivities, diff. spatial arrangement of atoms
■ Enantiomers: mirror images but nonsuperimposable
● Chiral C: C w/ 4 diff. groups
● # stereoisomers = 2(# chiral C’s in molecule) that is 2n

■ Diastereomers: are not mirror images


● Epimers: are different at 1 chiral center only. E.g., d-ribose and d-arabinose, which only differ at C-2

○ Absolute configuration
■ (R)/(S): CIP priority rules, (R) is Clockwise, (S) is Counterclockwise
■ (+)/(–): experimentally determined; (+) = d, (-) = l
■ ᴅ/ʟ: hydroxyl of penultimate C in Fischer projection (highest-number chiral C), ᴅ is right, ʟ is left
● In other words, sugars with the highest-numbered chiral carbon with the –OH group on the right, are d-
sugars, while those with the –OH on the left are l-sugars
○ Fischer projection
■ Horizontal lines are wedges (out from page), vertical lines are dashes (into page)

■ Highest-oxidized group is nearest to the top, start counting from that topmost C (C-1)
4.2. Cyclic Sugars
● Cyclization: describes the ring formation of carbohydrates from their strain chain forms
● Intramolecular ring formation: hydroxyl O (Nuc) attacks carbonyl C
○ Forms cyclic hemiacetals (from aldoses), hemiketals (ketoses)
■ Furanoses (5-membered), pyranoses (6-membered)
○ Carbonyl carbon (becomes anomeric carbon) becomes chiral
■ Anomers: epimers at anomeric C
● α: anomeric C ⦚–OH is trans (axial) to ⦚–MeOH
○ In other words, the -OH on the anomeric carbon is trans to the free-CH2OH group

● β: anomeric C ⦚–OH is cis (equatorial) to ⦚–MeOH (“what’s up, bitch”)


○ In other words, the -OH on the anomeric carbon is cis to the free-CH2OH group

● Haworth projection: represent 3D structure of monosaccharide


○ Cyclic sugars are planar rings, w/ groups above/below the plane
○ Left/right in Fischer = up/down in Haworth
○ ᴅ/ʟ: abs. configuration highest-number chiral C, ᴅ is (R), ʟ is (S)
● Mutarotation
○ Exposure to water (cat. acid/base) → spontaneous ring opening/closing → mutarotation between α, β
anomer
■ Mutarotation involves the interconversion between α, β anomer via ring opening and reclosing
○ In soln., β-glucose is more stable: equatorial ⦚–OH avoids 1,3-diaxial interactions
○ As solid, α-glucose is more stable: anomeric effect between O lone pairs, EN ⦚–OH (?)
■ Not very well understood, beyond scope of MCAT?
4.3. Monosaccharides
● Single carbohydrate units. Can undergo redox rns, esterification, and glycoside formation
● Redox
○ Reducing sugars: hemiacetal cyclic sugars
■ Aldonic acid: open-chain aldose after oxidation (aldehyde → CA), i.e., aldoses can be oxidized to
aldonic acids
■ Lactone: cyclic aldose after oxidation (hemiacetal → ester) (anomeric C hydroxyl → carbonyl)
■ Alditol: aldose after reduction (aldehyde → alcohol), i.e., aldoses can be reduced to alditols
■ Deoxy sugar: sugar w/ ⦚–H instead of ⦚–OH
○ Indicators for reducing sugars (aldoses, enol tautomer of ketoses)
■ Tollens’ reagent: diamminesilver (I)
● Preparation
○ 2 AgNO3 (aq) + 2 NaOH (aq) → Ag2O (s) + 2 NaNO3 (aq) + H2O (l)
○ Ag2O (s) + 2 NH3 (aq) + NaNO3 (aq) + H2O (l) → 2 [Ag(NH3)2]+ NO3– (aq) + 2 NaOH (aq)
● Creates Ag “silver mirror” in presence of reducing sugars
■ Benedict’s reagent: Cu(OH)2, etc.
● Precipitates red Cu2O in presence of reducing sugars
■ Glucose oxidase: tests for glucose only
● Esterification
○ Hydroxyls + CAs/CA derivs. → esters
■ In other words, sugars react with carboxylic acids, and their derivatives to form esters

○ Phosphorylation: is a similar rxn in which a phosphate ester is formed by transferring a phosphate group from ATP onto a
sugar

● Glycoside formation:
○ The basis for building complex carbohydrates and requires the anomeric carbon to link to another sugar
■ Example: Hemiacetals or hemiketals + alcohols + cat. acid → acetals or ketals (glycosides)
● Furanosides: are glycosides derived from furanoses
● Pyranosides: are glycosides derived from pyranoses
○ Glycosidic bonds: [sugar]–OR
■ Glycoside formation is a dehydration reaction; thus, breaking a glycosidic bond requires hydrolysis
■ Disaccharides and polysaccharides form as a result of glycosidic bonds between monosaccharides
4.4. Complex Carbohydrates
● Disaccharide: 2 monosaccharides, joined by glycosidic bond
○ Anomeric C ⦚–OH can react w/ any ⦚–OH on another sugar
○ Sucrose: Glc-α-1,2-β-Fru

○ Lactose: Gal-β-1,4-Glc

○ Maltose: Glc-α-1,4-Glc

● Polysaccharide: monosaccharide chains, joined by glycosidic bonds


○ Homopolysaccharide: made of 1 monosaccharide
○ Heteropolysaccharide: made of multiple monosaccharides
○ Cellulose: β-ᴅ-glucose, β-1,4 bonds
■ Cellulase: needed to hydrolyze cellulose, missing in humans but found in certain animals like cows, and goats
● Humans cannot digest any β-linked sugars
○ Starch: α-ᴅ-glucose; function as main storage form for plants
■ Amylose: α-1,4 bonds only, linear and unbranched
■ Amylopectin: α-1,4 and α-1,6 bonds, branched
■ Amylase: hydrolyzes starch
● α-amylase: cleaves any α-1,4 bond randomly
○ Yields small sugars
● β-amylase: cleaves every 2nd α-1,4 bond from nonreducing end (w/o available anomeric C)
○ Yields maltose only
● γ: cleaves α-1,4 bond from nonreducing end
○ Yields glucose only
■ Iodine is indicator
○ Glycogen: α-ᴅ-glucose, has more α-1,6 bonds than starch; function as main storage form for animals
■ Highly branched = energy efficiency ↑, solubility ↑, breakdown from many sites
■ Glycogen phosphorylase: cleaves glucose-1-P from glycogen
● Hers disease: glycogen phosphorylase deficiency → no glycogenolysis → hepatomegaly,
hypoglycemia

5. Lipids
5.1. Structural Lipids
● Phospholipids
○ Phosphate, alcohol (hydrophilic), fatty acid (FA) tails (hydrophobic)
○ Saturation
■ Saturated FAs: C–C single bonds only
● Stronger van der Waals forces, solid at room temp, less fluid
■ Unsaturated FAs: C=C double bonds
● Harder to pack, liquid at room temp, more fluid
● Glycerophospholipids/phosphoglycerides: glycerol (propanetriol) backbone
○ 2 FA tails linked by ester bonds
○ 1 head group linked by phosphodiester bond
■ Phosphatidylcholine: choline head group (⦚–O–CH 2–CH2–NMe3+)
■ Phosphatidylethanolamine: ethanolamine head group (⦚–O–CH 2–CH2–NH2)
● Sphingolipids: sphingosine/oid backbone
○ 1 FA tail linked by amide bond
■ Backbone itself is also a long-chain FA
○ 1 head group at 1-hydroxyl
■ Ceramide: H head group
■ Sphingomyelins: phosphatidylcholine/ethanolamine head group, linked by phosphodiester bond
● Sphingophospholipids
● Neutral, make up plasma membranes of myelinating cells
■ Glycosphingolipids: sugar head group, linked by glycosidic bond
● Not a phospholipid
● Neutral, found on outer surface of cell membranes
● Cerebrosides: 1 sugar as head group
● Globosides: multiple sugars as head group
■ Gangliosides: oligosaccharide head group, w/ sialic acid(s) (N-acetylneuraminic acid, NANA) at terminus
● Glycolipids, so not a phospholipid
● (–) charge, used for cell communication/recognition, signal transduction
● Waxes: esters of long-chain FAs w/ long-chain alcohols
○ Malleable solids at room temp
○ Repel water, lubricate, prevent dehydration
5.2. Signaling Lipids
● Terpenes, terpenoids: precursors for signaling lipids
○ Terpenes: built from isoprene (2-methyl-1,3-butadiene, H2C=C(Me)–CH=CH2)
■ Monoterpenes: 2 isoprenes
■ Sesquiterpenes: 3 isoprenes
■ Diterpenes: 4 isoprenes (e.g., retinol)
■ Triterpenes: 6 isoprenes
■ Tetraterpenes: 8 isoprenes (e.g., carotenoids)
■ Polyterpenes: many isoprenes (e.g., natural rubber)
○ Terpenoids: terpene derivs.
● Steroids: 3 cyclohexanes, 1 cyclopentane fused together
○ Steroid hormones: bound to carrier proteins, secreted into bloodstream, pass thru cell membrane (and nucleus)
○ Cholesterols
■ Found in plasma membranes, allow membrane fluidity
● Prevent solidifying in cold temps/hyperpermeability in high temps
■ Precursors for steroid hormones, bile acids, vit. D
● Prostaglandins: arachidonic acid derivs., unsaturated CAs w/ 1 cyclopentane
○ Para/autocrine signaling, regulate cAMP synthesis
○ Downstream effects: smooth muscle function, circadian rhythm, fever
○ Nonsteroidal anti-inflammatory drugs (NSAIDs): inhibit cyclooxygenase (COX) → prostaglandins ↓
● Fat-soluble vitamins
○ Vitamin A: carotene, retinal (aldehyde, light-sensing), retinol (alcohol, storage), retinoic acid (CA, hormone)
○ Vitamin D: cholecalciferol
■ Calcitriol: vit. D activated in liver/kidneys, intestinal Ca2+/PO43– uptake ↑ → osteogenesis
■ Rickets (vit. D deficiency): underdeveloped long bones, stunted growth
○ Vitamin E: tocopherols, tocotrienols (aromatic ring w/ long isoprenoid side chain)
■ Antioxidants: aromatic ring reacts w/ free radicals, prevents oxidative damage
○ Vitamin K: phylloquinone (vit. K1), menaquinones (vit. K2)
■ Post-translational modifications to form prothrombin (cleaved to form clotting factor thrombin)
● Warfarin: blood thinner, vit. K recycling ↓
■ Introduce Ca2+-binding sites
■ “Vit. K is for koagulation, kalcium”
5.3. Energy Storage
● Fat: stores energy better than sugar
○ High energy density: more reduced C’s → more oxidation possible
■ ~9 kcal/g, compared to ~4 kcal/g for carbs/proteins/ketone bodies
○ Hydrophobic: no hydration needed for stability → weight ↓
○ Insulation: retains body heat
○ But slower to recruit than glycogen
● Triglycerides/triacylglycerols: 3 FAs linked to glycerol backbone by ester bonds
○ Depots of metabolic fuel in cytosol
○ Adipocytes: fat storage under skin, in breast, abdominal cavity
● Saponification: hydrolyze esters in triglycerides
○ Triglyceride + 3 lye (NaOH) → glycerol + soap (free FA salts)
■ Free FAs: unesterified FAs w/ carboxylate groups, bind to serum albumin
○ Surfactant: surface tension ↓, dissolves both hydrophilic/phobic molecules
■ Water + fats + soap → colloid, amphipathic soaps form micelles around fats

6. DNA
6.1. Structure
● Nitrogenous bases
○ Purines (2 rings): adenine (A), guanine (G)
○ Pyrimidines (1 ring): cytosine (C), thymine (T), uracil (U)
■ “CUT the pye,” and pies have 1 ring
● Nucleoside: pentose and nitrogenous base, linked by glycosidic bond (C-1′ sugar to N-9 purine/N-1 pyrimidine)
● Nucleotide: nucleoside and 1–3 phosphates, linked by phosphodiester bonds (C-5′ sugar)
○ Pyrophosphate/phosphoanhydride bonds: phosphate–phosphate
■ High energy: electrostatic repulsion between (–)-charged phosphates
■ Breaking bonds is always endothermic, but cleaving Pi is exothermic
● Hydrolysis: ΔHbreaking (P)–(P) bond + ΔHforming (P)–water bond < 0
○ Deoxyribose: ribose w/ no ⦚–OH at C-2
○ Dideoxyribose: ribose w/ no ⦚–OH at C-2, C-3
● Nucleic acids: nucleotide polymers, linked by phosphodiester bonds
○ Ribonucleic acid (ssRNA), deoxyribonucleic acid (dsDNA)
○ Sugar–phosphate backbone: phosphate links C-3′ to C-5′
■ Nucleic acids are synthesized 5′ to 3′
○ (–) charge due to phosphates
● DNA double helix (Watson–Crick model)
○ Antiparallel ssDNA strands, backbone facing outward
○ Complementary base pairing: A–T (2 H bonds), G–C (3 H bonds)
○ Chargaff’s rules: # purines = # pyrimidines
■ Formed before base-pairing was known, doesn’t say %A = %T, %G = %C
○ B-DNA: right-handed helix, turns every 3.4 nm (~10 bases)
■ Major (protein binding sites), minor grooves
■ Most DNA
○ Z-DNA: left-handed helix, turns every 4.6 nm (~12 bases)
■ Uncommon/unstable, found in GC-rich DNA or high salinity
● Denaturation: heat, basic pH, formaldehyde, urea disrupt H bonds, separate ssDNA strands
● Reannealing: spontaneous complementary base pairing
6.2. Eukaryotic Chromosome Organization
● Human DNA: ~6 billion bp, 46 chromosomes
● Chromatin: “beads on a string”
○ DNA wrapped around histones (nucleoproteins)
■ Histone core: H2A, H2B, H3, H4
■ H1: keeps wrapped DNA in place, stabilizes chromatin
■ High Lys, Arg content: (+) charge attracts (–)-charged DNA backbone
○ Nucleosome: ~200 bp wrapped around histone core
○ Heterochromatin: dense, dark in light microscopy, silent
■ Highly repetitive sequences
○ Euchromatin: uncondensed, light in light microscopy, expressed
● Telomeres: TTAGGG repeats at ends of DNA
○ DNA replication can’t reach ends: DNA Pol falls off for lagging strand
○ Shortened w/ each replication → cellular aging
■ Hayflick limit: # times a cell can replicate before telomeres are too short for cell division
■ Telomerase: extends telomeres, not produced by most somatic cells
○ High GC-content: strong strand attractions at ends of DNA, prevents unraveling
● Centromeres: heterochromatin region at center of DNA
○ GC-rich tandem repeats
○ Site where 2 sister chromatids connect
6.3. Replication
● Initiation
○ Replisome/replication complexes assemble at each origin of replication (ori)
■ Prokaryotes
● Circular DNA, small genome → 1 ori, 2 replication forks
■ Eukaryotes
● Linear DNA, large genome → many ori’s, many replication forks to speed up replication
● Sister chromatids remain connected at centromere
● Elongation: reads 3′ to 5′, synthesizes daughter strands 5′ to 3′, semiconservative (1 parent strand in each daughter dsDNA)
○ Helicase: disrupts base–base H bonds, separates dsDNA into ssDNA strands
■ ss-binding proteins: prevent ssDNA from reannealing, prevent unwanted interactions, protect ssDNA from
nucleases
● SSB (prok.), rep. protein A (RPA, euk.)
■ Topoisomerases: relax supercoils upstream (ahead of helicase), prevent torsional pressure
● Induce ss/ds breaks, re-ligate DNA to prevent overwinding double helix
● Gyrase (prok.): targeted by broad-spectrum fluoroquinolone (…-floxacin) antibiotics
○ Priming: DNA-dependent RNA Pol, forms initial RNA primer to polymerize from
■ DNA cannot be synthesized de novo
■ Leading strand is primed once, lagging strand is primed every Okazaki fragment
■ Primase (prok.), DNA Pol α (euk., also adds some ssDNA after RNA primer)
○ Synthesis: 5′ to 3′
■ Strand’s 3′ ⦚–OH attacks free nucleotide’s 5′ phosphate
● Releases PPi → 2 Pi, drives Le Châtelier
■ Sliding clamp: strengthens DNA Pol–template strand interactions
● DNA Pol III β dimer (prok.), PCNA trimer (euk.)
● Loaded by clamp loader: DNA Pol III subunits (prok.), rep. factor C (RFC, euk.)
■ Leading, lagging strands
● Okazaki fragments: 1,000–2,000 bp (prok.), 100–200 bp (euk.)
● DNA Pol III (prok.), DNA Pol δ/ε (euk.), DNA Pol γ (mitochondria)
○ Removing primers, ligating nicks
■ 5′-to-3′ exonucleases: DNA Pol I (prok.), RNase H (euk.)
■ Fill in missing dNTPs: DNA Pol I (prok.), DNA Pol δ (euk.)
■ Ligate nicks/fragments: DNA ligase
○ Proofreading during replication
■ 3′-to-5′ exonucleases: all DNA Pol’s (prok.), DNA Pol δ/ε (euk.)
● Termination
○ Prokaryotes
■ Tus–Ter: Tus protein binds Ter sites, ensures one-way replication forks
■ Termination occurs at desired site
○ Eukaryotes
■ Replication terminates when replication forks meet
■ Telomeres cannot be fully replicated on lagging strand
● Okazaki fragments need primers upstream to elongate
● Okazaki fragments need DNA upstream to remove primer, else RNA primer is degraded
6.4. Repair
● Cancer: excessive division w/o stimulus or controls, migrates locally or systemically (metastasis)
○ Oncogenes: mutated genes that cause cancer
■ Proto-oncogenes: usually cell-cycle genes
■ 1 mutated allele is enough for tumor growth
○ Tumor suppressors/anti-oncogenes: stop tumor progression
■ p53, Rb, etc.
■ 2 mutated alleles needed for cancer
● Proofreading: fixes mismatches during replication (S phase)
○ Incorrect complementary base-pairing → unstable H bonds
○ 3′-to-5′ exonuclease: excises incorrect base on daughter strand (unmethylated)
○ Mutations are more common on lagging strand
■ DNA ligase lacks proofreading
■ Many more RNA primers, which are more error-prone
● Mismatch repair (MMR): fixes mismatches in G2
○ MutS, MutL (prok.), MSH2, MLH1 (euk.)
● Nucleotide excision repair (NER): fixes UV-induced damage in G1/G2
○ UV → cyclobutane pyrimidine dimer (CPD) lesion → bulge in DNA strand
○ Excision endonuclease: nicks backbone on both sides of CPD, removes oligonucleotide
■ Uvr’s (prok.), TFIIH, XPG, etc. (euk.)
○ Fill in 5′ to 3′ using undamaged strand as template (no primer needed), ligate nick
● Base excision repair (BER): fixes small, non-helix-distorting lesions in G1/G2
○ Heat → cytosine deaminates, turns into uracil
○ Glycosylase recognizes, removes base
■ Apurinic/apyrimidinic (AP)/abasic site: backbone w/o base
○ AP endonuclease excises neighboring sequence
○ Fill in 5′ to 3′, ligate nick
6.5. Biotechnology
● Restriction enzymes/endonucleases: recognize, cut specific dsDNA sequences
○ Many are palindromic: 5′ to 3′ = antiparallel 3′ to 5′
○ Sticky ends: overhangs of ssDNA
○ Blunt ends: no overhang
○ Types
■ I: randomly cuts far away (> 1,000 bp) between 2 recognition sites
● Needs ATP (to move along DNA), Mg2+, S-adenosyl Met (SAM)
■ II: specifically cuts close to or w/in recognition site (most common)
● Needs Mg2+, usually palindromic
■ III: randomly cuts between 2 inverse recognition sites (rare)
● Needs ATP (to move along DNA), Mg2+, SAM
■ IV: cuts methylated DNA
■ V: cuts using guide RNA (e.g., Cas9)
● DNA cloning: amplifies small sample sequence w/ a vector (bacterial, viral plasmid)
○ Cut vector w/ restriction enzyme
■ Typically at multiple cloning site (MCS), which has many known unique restriction sites
○ Insert foreign DNA, ligate
○ Transform competent bacteria w/ vector, grow into colonies
○ Isolate transformed colonies
■ Screening: visual indicator of transformation
● Blue–white screen: recombination disrupts lacZ → no β-galactosidase expression → no X-gal
hydrolysis
○ White colonies: recombinant vector (can’t hydrolyze X-gal into blue product)
○ Blue colonies: nonrecombinant vector, off-target recombination or no transformation
■ Selection: kill non-transformed bacteria
● Antibiotic-resistance gene in plasmid
○ Produce lots of recombinant protein, or lyse cells and use restriction enzyme to isolate lots of cloned DNA
● DNA library: large collection of known DNA sequences
○ Genomic library: coding, noncoding regions
■ Chromosomal DNA, cut w/ restriction enzymes
○ Expression library: coding regions only
■ Complementary DNA (cDNA): reverse-transcribed processed mRNA
■ Complete, expressible gene sequences
● Polymerase chain reaction (PCR): amplifies DNA sequence
○ Melt dsDNA into single strands w/ heat
○ Anneal complementary primers, which hybridize
■ GC-rich, lower temp for more stability
○ Extend w/ free dNTPs and Taq Pol
■ Taq Pol: thermostable DNA Pol I, from thermophilic Thermus aquaticus bacteria
● Gel electrophoresis: separates DNA by sequence length
○ All DNA is (–)-charged b/c of backbone phosphates, migrate to anode
■ In all cells, anode attracts anions
■ In electrochemical cells, anode is (+)
○ Longer DNA migrates slower thru agarose gel
○ Plasmid thru gel electrophoresis
■ Supercoiled: travels faster than circular plasmid (much smaller size)
■ Linear: travels a little faster than circular plasmid (less bulky), migrates distance expected from DNA length
● Southern blot: detects, quantifies DNA strands
○ Cut DNA w/ restriction enzymes, separate fragments w/ gel electrophoresis
○ Transfer fragments to nitrocellulose membrane w/ pressure (capillary action), bake fragments onto membrane
○ Probe membrane w/ labeled ssDNA hybridization probes
○ Wash excess probe, visualize probed DNA
● Sanger sequencing
○ Replicate DNA w/ small amounts of fluorescent dideoxyribonucleotides (ddNTPs)
■ No ⦚–OH at C-2′ or C-3′, elongation cannot occur
○ Separate resulting fragments w/ gel electrophoresis
○ Read each base in order
● DNA technology applications
○ Gene therapy: transduces functional gene into human cells w/ modified retroviruses
■ Vector can infect cells but not replicate
■ Randomly integrated DNA can disrupt proto-oncogenes/tumor suppressors, chance of cancer ↑
○ Transgenesis: microinjects cloned gene (transgene) into fertilized ova/embryonic stem cells
■ Alters germ line, produces transgenic offspring
■ Knockout: delete/disable a specific gene
■ Chimera: inject transgenic embryonic stem cells into developing blastocysts

7. RNA
7.1. Genetic Code
● Central dogma: (replication) ⟳ DNA ⤚(transcription)→ RNA ⤚(translation)→ protein
● RNA types
○ Ribosomal RNA (rRNA): forms peptide bonds in ribosome, splices introns
■ Transcribed by RNA Pol I
■ Ribozymes: enzymatic RNA
○ Messenger RNA (mRNA): info for AA sequence
■ Transcribed by RNA Pol II from DNA template strand
● mRNA sequence is identical to coding strand (except T → U)
■ Polycistronic (prok.): 1 mRNA can encode multiple proteins
■ Monocistronic (euk.): 1 mRNA → 1 protein
○ Transfer RNA (tRNA): delivers corresponding AA to ribosome
■ Transcribed by RNA Pol III
■ Anticodon: complementary to codon
■ Aminoacyl-tRNA (aa-tRNA) synthetase: charges/activates tRNA at 3′ ⦚–OH w/ correct AA
● Charging requires ATP → AMP + PPi
● Codon: 3 bases = 1 AA
○ 61 codons encode AAs, 3 encode stop codons
○ Start codon (AUG): Met, starts translation
○ Stop codons (UAA, UGA, UAG): bind release factors instead of tRNA, stops translation
■ “U Are Annoying, U Go Away, U Are Gone”
○ Degeneracy: many codons encode 1 AA
■ Wobble position: 3rd base is variable
● Mutations are silent/degenerate/synonymous
● Redundancy → more fault tolerance for point mutations
○ Anticodon on tRNA: pairs w/ complementary, antiparallel codon on DNA
● Point mutations
○ Silent: mutated codon encodes same AA (degenerate)
○ Missense: mutated codon encodes different AA
○ Nonsense/truncation: mutated codon encodes stop
○ Frameshift: base is inserted/deleted (indel), entire reading frame shifts
7.2. Transcription
● DNA must be transcribed before leaving nucleus
● Template strand map in eukaryotes, from 5′ to 3′
○ Promoter (CAAT box, TATA box), transcription start site (TSS, +1)
○ 5′ untranslated region (UTR), start codon, exons/introns, stop codon, 3′ UTR (poly(A) signal)
○ Terminator
● Initiation
○ RNA Pol (DNA-dependent RNA Pol), transcription factors (TFs) bind promoter
■ RNA Pol binds Pribnow box (prok.), RNA Pol II binds TATA box (euk., ~ –25)
■ TFs bind CAAT box (euk., ~ –70)
● Elongation: RNA Pol II reads template strand 3′ to 5′, synthesizes pre-mRNA 5′ to 3′
○ No priming (RNA Pol) or Okazaki fragments (reading only the template strand) needed
○ Less accurate than DNA replication
○ Produces heterogeneous nuclear RNA (hnRNA)/pre-mRNA
● Termination: RNA Pol reaches terminator sequence, stops transcribing
○ Prokaryotes
■ Rho factor method
● RNA Pol stalls after reaching terminator
● Rho binds rho utilization site (rut, C-rich) on transcript, travels down the transcript using ATP, unwinds
transcript from template DNA
■ Hairpin method
● Terminator sequence is GC-rich palindrome, followed by chain of A’s
● Transcript self-anneals into hairpin (strong H bonds), followed by chain of A–U’s (weak H bonds)
● NusA binds hairpin, stalls RNA Pol, weak A–U duplex unwinds
○ Eukaryotes
■ RNA Pol II transcribes poly(A) signal
■ CPSP (cleavage and polyadenylation specificity factor) and CstF (cleavage stimulation factor) transfer from RNA
Pol II to poly(A) signal transcript
■ Recruited proteins cleave transcript, add poly(A) tail to pre-mRNA
● Post-transcriptional modifications
○ Splicing: remove introns (noncoding), ligate exons (coding)
■ Spliceosome: small nuclear RNA (snRNA) + small nuclear ribonucleoproteins (snRNPs)
● Binds intron, recognizes 5′, 3′ splice sites and brings them closer together
● Exons ligate, intron is excised as lariat
■ Alternative splicing: 1 hnRNA can be spliced in diff. ways to produce diff. proteins
○ 5′ cap: 7-methylguanylate triphosphate (m7Gppp) at 5′ end
■ Capping occurs during transcription
● Remove 1 phosphate from 5′ terminal NTP
● Add GTP backwards → 5′–5′ triphosphate bond + PPi
● Methylate N-7 of Gppp
■ Ribosomal binding site during translation
■ Regulates nuclear export, protects mRNA from degradation in cytoplasm
■ Mitochondrial/chloroplast/prokaryotic mRNA lack 5′ caps
● Some bacteria have other caps
○ Poly(A) tail: chain of A’s at 3′ end
■ Polyadenylation occurs as transcription terminates
■ Protects mRNA from degradation in cytoplasm
● Once in cytoplasm, mRNA starts being degraded 3′ to 5′
● Longer poly(A) tail = longer survival in cytoplasm
■ Regulates nuclear export
■ Prokaryotes: poly(A) tail marks mRNA for degradation (!)
● Export: processed mRNA leaves nucleus thru nuclear pores
7.3. Translation
● Ribosome: rRNA + ribosomal proteins (RPs)
○ Large, small subunits: bind only during translation
■ Prokaryotes: total 70S
● Large (50S): 23 + 5S rRNA
● Small (30S): 16S rRNA
■ Eukaryotes: total 80S (all even numbers for subunits, 1828585 for rRNA components)
● Large (60S): 28 + 5.8 + 5S rRNA
● Small (40S): 18S rRNA
● RNA Pol I transcribes 45S pre-rRNA (28 + 18 + 5.8S) in nucleolus
● RNA Pol III transcribes 5S rRNA outside nucleolus
● Initiation
○ Small subunit binds mRNA at 5′ end, initiator tRNA binds start codon
■ Prokaryotes: Shine–Dalgarno sequence in 5′ UTR, fmet-tRNA
■ Eukaryotes: 5′ cap, met-tRNA
○ Small subunit travels down mRNA until it reaches start codon
○ Large subunit binds small subunit thru initiation factors (IFs)
● Elongation: ribosome reads mRNA 5′ to 3′, synthesizes protein N- to C-terminus
○ Ribosome sites: “APE”
■ A site: holds incoming aa-tRNA
● EF-Tu (prok.)/EF-1A (euk.) carries aa-tRNA to A site, uses GTP to dissociate itself
● EF-Ts (prok.)/EF-1B (euk.) releases GDP from EF-Tu/EF-1A
■ P site: holds tRNA carrying polypeptide chain
● Peptidyl transferase: forms peptide bond between A-site AA and P-site polypeptide using GTP
● EF-G (prok.)/EF-2 (euk.) moves tRNA/mRNA down the ribosome
■ E site: uncharged tRNA exits ribosome
○ Signal sequence: short N-terminus peptide, indicates destination for protein
■ Secretory, membrane, lysosomal proteins
● Ribosome migrates, attaches to ER
● Signal peptidase removes signal sequence, translation continues
● Protein is glycosylated in ER, transferred to Golgi apparatus, exported
● Termination: release factor (RF) binds stop codon
○ No aa-tRNA exists for stop
○ Peptidyl transferase, termination factors hydrolyze polypeptide from tRNA
○ Ribosomal subunits dissociate
● Post-translational modifications (euk.)
○ Chaperones: ensure correct protein folding
■ Proteins can be misfolded, native state is not always the lowest-energy
○ Cleavage: removes signal sequence, cleaves zymogens, cleaves polyproteins (in prok.)
○ 4° interactions
○ Phosphorylation: by kinases, de/activates protein
○ Carboxylation: adds CA groups to be Ca2+-binding sites
○ Glycosylation: adds oligosaccharides, indicates cellular destination
○ Prenylation: adds lipid groups to membrane-bound enzymes
7.4. Prokaryotic Gene Regulation
● Operon: gene cluster governed by 1 promoter, transcribed on 1 mRNA
● Jacob–Monod model (from upstream to downstream)
○ Regulator: encodes repressor
○ Promoter: binds RNA Pol
○ Operator: binds repressor
○ Structural gene: encodes actual protein
● (+) control: protein binds DNA → transcription ↑
● (–) control: protein binds DNA → transcription ↓
● Inducible systems: expression is off by default
○ Default: repressor is bound to operator, blocks RNA Pol
○ Inducer binds and removes repressor, RNA Pol can proceed
○ e.g., lac operon: encodes most lactase when high [lactose], low [glucose]
■ Using lactose is more expensive than using glucose
■ Lactose is inducer, (–) control
■ Catabolite activator protein (CAP): transcriptional activator, (+) control
● Glucose ↓ → cAMP ↑, cAMP binds CAP, CAP binds promoter
■ High [lactose], low [glucose]: most expression
■ High [lactose], high [glucose]: basal (low) expression
■ Low [lactose]: no expression
● Repressible systems: expression is on by default
○ Default: free repressor can’t bind operator, RNA Pol can proceed
○ Corepressor binds repressor, complex binds operator, RNA Pol is blocked
■ (–) feedback: final product = corepressor
○ e.g., trp operon: synthesizes most Trp when low [Trp]
■ Trp is corepressor, (–) control
■ Low [Trp]: expression
■ High [Trp]: no expression, (–) feedback
7.5. Eukaryotic Gene Regulation
● Transcription factors (TFs): transcriptional activators
○ DNA-binding domain: binds TF-binding site (TFBS) in response element (promoter/enhancer)
○ Activation domain: binds other TFs, RNA Pol, histone acetylases, etc.
○ Signal molecules: steroid hormones/2nd messengers bind nuclear receptors, which act as TFs
● Gene amplification: amplifies expression from basal (default, low) levels
○ Enhancers: TFBSs very far away from TSS (~1,000 bp away), either upstream or downstream
■ DNA bends to bring enhancer-bound TFs and promoter-bound TFs together
○ Insulators: block enhancers by changing DNA’s 3D structure
■ Bound by CCCTC-binding factors (CTCFs, a kind of TF)
■ Methylating insulators blocks CTCF-binding, disables insulators
○ Gene duplication: copies gene in series/parallel on same chromosome
● Chromatin remodeling
○ Heterochromatin: tightly coiled, inaccessible to TFs, inactive
○ Euchromatin: loosely coiled, TFs can bind, active
○ Histone acetylation: acetylates histone Lys, opens chromatin
■ Acetylated Lys is no longer (+)-charged, weaker DNA–histone interactions
■ Histone de/acetylases
○ DNA methylation: methylates C’s in CpG (and A’s), silences gene
■ Methyl groups block TF-binding or recruit transcriptional repressors
■ 5-methylcytosine (m5C) can spontaneously deaminate into T

8. Membranes
8.1. Fluid Mosaic Model
● Plasma membrane: semipermeable phospholipid bilayer
○ Bilayer: double layer of amphipathic phospholipids
○ Selective permeability: small nonpolar neutral molecules can diffuse thru membrane
■ Others need channels/carriers
○ Glycoprotein coat: carbs associated w/ membrane proteins
■ Cell wall: plants, bacteria, fungi
● Fluid mosaic: phospholipids freely, rapidly move within layer by diffusion
○ Lipid rafts: collections of similar lipids, attachment points for other molecules
■ Involved in signaling
○ Flippases: flip phospholipids between layers
■ Unfavorable, since polar head must cross nonpolar interior of membrane
8.2. Components
● Lipids
○ Glycerophospholipids: triacylglycerols w/ 2 FAs + 1 phosphate group, amphipathic
■ Spontaneous assembly into micelles (monolayer), liposomes (bilayer)
■ Unsaturated FAs: liquid at room temp, fluidity ↑
● Most cannot be synthesized, obtained thru diet
■ Saturated FAs: solid at room temp, fluidity ↓
○ Sphingolipids: sphingosine (or sphingosine deriv.) backbone, amphipathic
■ Ceramides (H), sphingomyelins (phosphatidylcholine/ethanolamine), cerebrosides (sugar), gangliosides
(polysaccharide)
○ Cholesterols: stabilize membranes, amphipathic
■ Low temps: prevents crystalline packing between phospholipids, fluidity ↑
■ High temps: hinders phospholipid movement, fluidity ↓
■ Cell membranes have high cholesterol:phospholipid ratios to ensure fluidity
● ~20% of membrane by mass, ~50% of membrane by amount
■ Steroid precursors
○ Waxes: long-chain FA + long-chain alcohol, extremely hydrophobic
■ Stability, rigidity ↑ in interior of membranes
■ Rare in animal membranes
● Proteins
○ Integrated: associated w/ interior of cell membrane
■ Transmembrane: pass completely thru bilayer (e.g., transporters, channels, receptors)
● Receptors: ligand-gated channels, signal transduction (e.g., GPCRs), etc.
■ Embedded: associated w/ cytoplasmic or extracellular surface only
○ Membrane-associated/peripheral
■ Electrostatically bound to bilayer (lipid rafts), bound to other proteins, etc.
● Carbs: cell signaling, recognition (e.g., ABO antigens)
○ Attached to glycoproteins, glycolipids
● Cell junctions: direct intercellular communication
○ Cell adhesion molecules (CAMs): allow cell recognition, help proper differentiation/development
○ Gap junctions/connexons: direct cell–cell communication
■ Connexin hexamers
■ Water, some solutes can pass through
■ e.g., electrical junctions, intercalated discs of cardiac muscle
○ Tight junctions: impermeable (prevent paracellular transport), physical links between epithelial cells
■ Continuous bands around cell to ensure tight seal
○ Desmosomes: bind adjacent cells by anchoring their cytoskeletons together
■ Transmembrane proteins (cadherins) associated w/ intermediate filaments (keratin)
■ Found in interfaces between epithelial layers
■ Hemidesmosomes: attach epithelial cells to basement membrane
8.3. Membrane Transport
● Passive transport: no energy needed (spontaneous, ΔG < 0), driven by ΔS > 0
○ Simple diffusion: particles move down concentration gradient thru membrane
■ Small nonpolar neutral molecules only
■ Osmosis: diffusion of water
● Water moves from low [solute] to high [solute] (a.k.a. from high [water] to low [water])
● Tonicity
○ Hypotonic: [intracellular] < [extracellular], water moves into cell
■ Lysis (animals), turgid (plants)
○ Isotonic: [intracellular] = [extracellular], no net water movement
○ Hypertonic: [intracellular] > [extracellular], water moves out from cell
■ Crenation (animals), plasmolysis (plants)
● Osmotic pressure: Π = iMRT, where i = van ’t Hoff factor
○ Hydrostatic pressure exerted on lower-conc. compartment, opposes further influx of water
○ “Sucking” pressure: draws water into cell in proportion to [soln.]
○ Colligative property: depends only on [solute], not on the identity of those solutes
○ Facilitated diffusion: diffusion of impermeable particles
■ Large, polar or charged molecules
■ Carriers: open to only 1 side of membrane at a time
● Substrate binds carrier, carrier changes conformation, substrate dissociates into cell
○ Occluded state: carrier is closed to both sides during conformational change
■ Channels: open to both sides of membrane
● Closed, inactivated states
● Active transport: requires energy (nonspontaneous, ΔG > 0)
○ Particles move against concentration gradient
○ Primary: uses energy (ATP hydrolysis) to power transport directly
■ Transmembrane ATPases
○ Secondary/coupled: harnesses energy of another particle moving down its gradient
■ Symport/cotransport: both particles flow in same direction
● e.g., Na+/glucose cotransporter in small intestine, kidney proximal tubules
■ Antiport/exchange: particles flow in opposite directions
● Endocytosis: plasma membrane invaginates, engulfs material in vesicle
○ Certain membrane receptors trigger endocytosis, vesicle-coating proteins (clathrin) invaginate membrane
○ Pinocytosis: fluids, dissolved particles
○ Phagocytosis: large solids (e.g., bacteria)
● Exocytosis: secretory vesicle fuses w/ plasma membrane, material is released
○ e.g., neurotransmitter release from synaptic vesicles into synaptic cleft
8.4. Specialized Membranes
● Membrane potential (Vm): diff. in electrical potential across membrane
○ Electrochemical (EC) gradient: forms from ion impermeability and ion-channel selectivity
○ Resting potential: –40 to –80 mV
○ Maintaining membrane potential requires energy
■ Leak channels: ions passively diffuse through membrane
● K+ leaks out over time: cell membranes are more permeable to K+
○ # K+ leak channels ≫ # Na+ leak channels
■ Na+/K+ pump (Na+/K+-ATPase): maintains low [Na+], high [K+] inside cell
● Uses energy to transport 3 Na+ out, 2 K+ in
● Net –1 charge each time
○ Nernst equation: Eion = RT/(zF) ln [outside]/[inside], where z = charge of ion, F = Faraday constant
■ At body temp, Eion ≈ (62 mV)/z log [outside]/[inside]
■ Goldman–Hodgkin–Katz voltage equation:
● Vm = (62 mV) log (PNa+[outside] + PK+[outside] + PCl–[inside])/(PNa+[inside] + PK+[inside] + PCl–[outside]),
where P = permeability of ion
○ Note: inside/outside for Cl– is reversed, b/c Cl– is (–)-charged
● Mitochondrial membranes
○ Outer membrane: large pores, highly permeable (ions, small proteins)
■ Encloses intermembrane space
○ Inner membrane: much less permeable, cristae (infoldings) increase SA
■ Encloses mitochondrial matrix: citric acid cycle
■ High [cardiolipin], no cholesterols in membrane

9. Glycolysis, Gluconeogenesis, Pentose Phosphate Pathway


9.1. Glucose Transporters
● GLUT1: transporter in RBCs, blood–brain barrier, placenta
● GLUT2: low-affinity (high Km) transporter in liver, pancreatic β cells, kidney prox. tubules, small intestine
○ Doesn’t respond to insulin
○ 1st-order kinetics: rate of uptake ∝ [glucose]
○ In liver cells: captures, stores excess glucose in hepatic portal vein after a meal
■ If [glucose] < Km, then most glucose bypasses liver, enters peripheral circulation
○ In pancreatic β cells: acts as glucose sensor
● GLUT3: very high-affinity (very low Km) transporter in neurons, sperm
● GLUT4: high-affinity (low Km ≈ [blood sugar]), insulin-dependent transporter in fat, muscle
○ Insulin → more GLUT4 on surface, uptake Glucose faster
○ Zero-order kinetics: constant uptake, independent of [glucose]
■ Transporter is saturated slightly above [blood glucose]
○ In muscles: excess glucose → glycogen
○ In fat: excess glucose → … → dihydroxyacetone phosphate (DHAP)
■ DHAP + NADH ⥫(glycerol 3-P DH (GPDH))⥬ glycerol 3-P + NAD + → … → triacylglycerols

9.2. Glycolysis
● Breaks down glucose into 2 pyruvate, producing some energy
● Occurs in cytoplasm
● Net: glucose + NAD+ + 2 ADP + 4 Pi → 2 pyruvate + 2 NADH + 2 ATP
● Steps
○ Glucose (Glc) + ATP ⤚(hexokinase)→ Glc 6-P (G6P) + ADP
■ Traps Glc from leaking out thru GLUT’s
■ Irreversible rxn.: attaching phosphate requires energy, but some energy from ATP hydrolysis is wasted
■ Hexokinase: in most tissues
● Lower Km (need Glc for energy), lower vmax (saturated even during fasting)
● Inhibited by G6P (enough Glc in glycolysis)
● Hexokinase has a much higher affinity for glucose than its isozyme, glucokinase
■ Glucokinase: in liver, pancreatic β islets
● Higher Km (save Glc from energy-storage pathways), higher vmax (quickly adjust blood sugar)
● Induced by insulin
○ G6P ⥫(G6P isomerase)⥬ Fru 6-P (F6P)
■ Sets up aldol cleavage later
○ F6P + ATP ⤚(phosphofructokinase-1 (PFK-1))→ Fru 1,6-bisP (F1,6BP) + ADP
■ Rate-limiting, irreversible rxn.: commits Glc to oxidation
■ Main control point in glycolysis
● Activated by AMP: not enough ATP in cell
● Inhibited by ATP, citrate: enough energy in cell
● In liver: hormonal control thru PFK-2
○ PFK-2 converts a tiny amount of F6P to F2,6BP, which activates PFK-1
○ Activated by insulin, inhibited by glucagon
○ Overrides (–) feedback from ATP, excess glycolysis products are stored as glycogen/FAs/etc.
○ F1,6BP ⥫(aldolase A)⥬ glyceraldehyde 3-P (GAP) + dihydroxyacetone phosphate (DHAP)
■ Splits hexose into 2 trioses
○ DHAP ⥫(triose phosphate isomerase (TPI))⥬ GAP
■ Only GAP can proceed in glycolysis
○ GAP + NAD+ + Pi ⥫(GAPDH)⥬ 1,3-bisphosphoglycerate (1,3BPG) + NADH
■ Oxidizes GAP, reduces NAD+, excess energy is used to attach a phosphate
● NADH is oxidized for energy (aerobic) or for Le Châtelier’s principle (anaerobic)
■ Produces unstable anhydride
○ 1,3BPG + ADP ⥫(phosphoglycerate kinase (PGK))⥬ 3-phosphoglycerate (3PG) + ATP
■ Cleaves anhydride, uses energy to form ATP
○ 3PG ⥫(phosphoglycerate mutase (PGM))⥬ 2PG
○ 2PG ⥫(enolase)⥬ phosphoenolpyruvate (PEP) + H2O
■ Dehydration creates high-energy trapped enol
● Cannot tautomerize to more stable keto, b/c O is bound to phosphate
○ PEP + ADP ⤚(pyruvate kinase (PK))→ pyruvate + ATP
■ Irreversible rxn.
■ Feedforward activation: activated by F1,6BP
● Fermentation
○ In anaerobic respiration, Le Châtelier’s principle stops/reverses glycolysis
■ Pyruvate, NADH build up
■ To drive glycolysis, pyruvate is reduced as waste, NADH is reoxidized
○ Lactic acid fermentation in humans
■ Pyruvate + NADH ⥫(lactate DH)⥬ lactate + NAD+
○ Ethanol fermentation in yeast
■ Pyruvate ⥫(pyruvate decarboxylase)⥬ acetaldehyde + CO 2
○ Acetaldehyde + NADH ⥫(alcohol DH)⥬ ethanol + NAD +
● Glycolysis products
○ DHAP: used in fat, liver for synthesizing triacylglycerol
■ Reduces to glycerol 3-P, dephosphorylates to glycerol
○ 1,3BPG, PEP: transfer their phosphates to produce ATP
■ Only source of ATP in anaerobic respiration
○ Pyruvate
■ Anaerobic respiration: wasted as lactate
■ Aerobic respiration: enters citric acid cycle as acetyl-CoA
■ Gluconeogenesis: converted to oxaloacetate by pyruvate carboxylase (PC)
● Glycolysis in RBCs
○ RBCs lack mitochondria, anaerobic glycolysis is only source of ATP
○ BPG mutase (BPGM): isomerizes 1,3BPG to 2,3BPG
■ 2,3BPG binds β chains of hemoglobin A (HbA), oxygen affinity ↓
● Does not bind fetal hemoglobin (HbF): allows fetus to get oxygen thru placenta
■ Unloads more oxygen during exercise
9.3. Other Monosaccharides
● Galactose (Gal) metabolism: turns Gal into Glc 1-P
○ Net: Gal + ATP → Glc 1-P + ADP
○ Steps
■ Lactose ⤚(lactase)→ Glc, Gal
■ Gal + ATP ⤚(galactokinase)→ Gal 1-P + ADP
● Traps galactose in cell
■ Gal 1-P + UDP-Glc ⥫(Gal 1-P uridylyltransferase (GALT)) ⥬ Glc 1-P (G1P) + UDP-Gal
■ UDP-Gal ⥫(epimerase)⥬ UDP-Glc
● Epimerases: converts 1 sugar epimer to another
■ Glucose enters its metabolism
○ Diseases
■ Lactose intolerance: no lactase
● 1°: hereditary
● 2°: damage to intestinal lining containing lactase
● Symptoms are from bacterial lactose fermentation → methane, H 2, small organic acids
■ Galactosemia: no galactokinase or GALT
● Gal ⤚(aldose reductase)→ galactitol
● Galactitol buildup in lens causes osmotic damage, cataracts
● Fructose (Fru) metabolism: turns Fru into glycolysis intermediates
○ Net: Fru + 2 ATP → 2 GAP + 2 ADP
○ Steps
■ Sucrose ⤚(sucrase)→ Glc, Fru
■ Fru + ATP ⤚(fructokinase)→ Fru 1-P + ADP
■ Fru 1-P ⥫(aldolase B)⥬ DHAP + glyceraldehyde
■ Glyceraldehyde + ATP ⤚(triokinase)→ GAP + ADP
■ DHAP, GAP enter glycolysis
9.4. Pyruvate Dehydrogenase
● Found in mitochondrial matrix
● Net: pyruvate + CoASH + NAD+ → acetyl-CoA + CO2 + NADH
● Steps
○ E1: pyruvate DH (PDH)
■ Decarboxylates pyruvate, stabilizes resulting carbanion w/ thiamine PPi (TPP) and Mg2+
■ Oxidizes carbonyl (into basically CA), reduces lipoamide, and attaches the resulting acetyl to it
○ E2: dihydrolipoyl transacetylase
■ Transfers acetyl to CoA, storing redox energy in thioester
○ E3: dihydrolipoamide DH
■ Oxidizes and restores lipoamide, shuttling its 2 e– to FAD
■ Shuttles 2 e– from FADH2 to NAD+
● Regulation
○ Activated by insulin in liver
○ Inhibited by ATP, NADH, acetyl-CoA
○ PDH kinase: phosphorylates, inhibits PDH in high [ATP]
○ PDH phosphatase: dephosphorylates, activates PDH in high [ADP]
9.5. Glycogen
● Glycogen: glucose storage, stored in cytoplasm as granules
○ Synthesized/degraded in liver, skeletal muscles
● Glycogenesis
○ Net: Glc + ATP + UTP → glycogen + ADP + UDP + PP i
○ Steps
■ Glucose + ATP ⤚(glucokinase)→ G6P + ADP
■ G6P ⥫(phosphoglucomutase)⥬ G1P
■ G1P + UTP → UDP-Glc + PPi
● Activates Glc to allow integration into glycogen
■ UDP-Glc ⤚(glycogen synthase)→ glycogen + UDP
● Glycogen synthase: forms α-1,4 glycosidic bonds, rate-limiting
○ Activated by G6P, insulin
○ Inhibited by Epi, glucagon
● Branching enzyme: adds α-1,6-linked branches
○ Breaks α-1,4 bond
○ Moves free oligoglucose, forms α-1,6 bond
● Glycogenolysis
○ Net: glycogen → Glc
○ Steps
■ Glycogen + Pi ⤚(glycogen phosphorylase)→ G1P
● Glycogen phosphorylase: breaks α-1,4 glycosidic bonds, rate-limiting
○ Activated by glucagon (liver), Epi, AMP (skeletal muscle)
● Debranching enzymes
○ Breaks α-1,4 bond adjacent to branch point
○ Moves free oligoglucose to exposed end, forms α-1,4 bond
○ Breaks α-1,6 bond, releasing free Glc
■ G1P ⥫(phosphoglucomutase)⥬ G6P
■ G6P ⤚(G6Pase)→ glucose + Pi
● von Gierke’s disease: G6Pase defect
○ No gluconeogenesis, need constant supply of carbs
○ G6P buildup in liver → liver damage

9.6. Gluconeogenesis
● Liver (and kidneys) synthesize glucose during fasting
○ Activated by Epi, glucagon
○ Inhibited by insulin
● Sources (G3OL)
○ Oxaloacetate from citric acid cycle (cataplerosis)
■ Oxaloacetate is reduced to malate (oxaloacetate can’t leave mitochondria)
■ Malate–Asp shuttle: transports malate into cytoplasm, antiport w/ α-ketoglutarate
■ Malate is oxidized back to oxaloacetate
○ Galactose, fructose metabolism
○ Lactate from anaerobic glycolysis
■ Lactate ⥫(lactate DH)⥬ pyruvate
○ Glycerol 3-P from triacylglycerols
■ Glycerol 3-P + NAD+ ⥫(GPDH)⥬ DHAP + NADH
■ DHAP enters reversed glycolysis
○ Glucogenic AAs
■ Ala + α-ketoglutarate (α-KG) ⥫(Ala aminotransferase)⥬ pyruvate + Glu
■ etc.
● Net: pyruvate + bicarbonate + ATP + GTP → Glc + ADP + GDP + 2 P i + CO2
● Steps
○ Pyruvate + bicarbonate + ATP ⤚(PC)→ oxaloacetate + ADP
■ Activated by acetyl-CoA
● This acetyl-CoA must come from β-oxidation of FAs
■ Biotin w/ Lys side chain
○ Oxaloacetate + GTP ⤚(PEP carboxykinase (PEPCK))→ PEP + GDP + CO 2
■ Activated by cortisol, glucagon
○ PEP ⇌ … ⇌ F1,6BP
○ F1,6BP ⤚(F1,6BPase)→ F6P + Pi
■ Irreversible (not coupled to anything, energy wasted), rate-limiting step
■ Activated by ATP
■ Inhibited by AMP, F2,6BP
○ F6P ⇌ G6P
○ G6P ⤚(G6Pase)→ glucose + Pi
■ Found only in ER lumen of liver cells
● G6P is transported into ER, glucose is transported out of cell
● No G6Pase in skeletal muscle: glycogen is burned within muscle only, not exported
○ Glycolysis can occur in all cells, while gluconeogenesis cannot
9.7. Pentose Phosphate Pathway
● Pentose phosphate pathway (PPP)/hexose monophosphate (HMP) shunt
○ Occurs in cytoplasm of all cells
○ Produces NADPH: e– donor, reducing agent in rxns.
■ FA/cholesterol synthesis
■ Bleach synthesis in WBCs: bactericide
■ Glutathione synthesis: antioxidant
● G6PDH deficiency: no PPP → no glutathione → more oxidative stress
○ Produces ribose 5-P: for nucleotides
● Glucose → G6P
● G6P + H2O + NADP+ ⤚(G6P dehydrogenase (G6PDH))→ 6-phosphogluconate + H+ + NADPH
○ Rate-limiting step
○ Activated by NADP+, insulin
○ Inhibited by NADPH
● 6-phosphogluconate + NADP+ → ribulose 5-P + NADPH + CO2
● Ribulose 5-P ⇌ ribose 5-P ⇌ [a bunch of 4–7 C sugars]
○ Equilibrated pool of sugars for biosynthesis
■ e.g., ribose 5-P is used for making RNA/DNA

10. Aerobic Respiration


10.1. Sources of Acetyl-CoA
● Pyruvate dehydrogenase (PDH) complex
○ Found in mitochondrial matrix
○ Net: pyruvate + CoASH + NAD+ → acetyl-CoA + CO2 + NADH
○ Steps
■ E1: PDH
● Decarboxylates pyruvate, stabilizes resulting carbanion w/ thiamine PPi (TPP) and Mg2+
● Oxidizes carbonyl, reduces lipoamide, and attaches the acetyl to it
■ E2: dihydrolipoyl transacetylase
● Transfers acetyl to CoA, storing redox energy in thioester
■ E3: dihydrolipoamide DH
● Oxidizes and restores lipoamide, shuttling its 2 e– to FAD
● Shuttles 2 e– from FADH2 to NAD+
○ Regulation
■ Inhibited by ATP, NADH
■ PDH kinase: phosphorylates, inhibits PDH in high [ATP]
■ PDH phosphatase: dephosphorylates, activates PDH in high [ADP]
● β-oxidation
○ FA + ATP + CoASH → acyl-CoA + AMP + PPi
■ Activates FA
○ Acyl-CoA ⇌ acyl-carnitine + CoASH
■ Transesterification: FA-carnitine shuttles into mitochondrion, acyl-CoA re-forms
○ Mitochondrial acyl-CoA is β-oxidized into acetyl-CoA’s
● AA catabolism
○ Transamination: ketogenic AAs ⇌ ketone bodies
● Ketone bodies
○ Formed in liver, converted into acetyl-CoA
○ Main energy source for brain during starvation
● Alcohol
○ Ethanol ⥫(alcohol DH)⥬ acetaldehyde ⤚(acetaldehyde DH)→ acetate
○ NADH also builds up → citric acid cycle ↓
○ Acetyl-CoA from alcohols goes into FA synthesis
10.2. Citric Acid Cycle
● Citric acid/Krebs/tricarboxylic acid (TCA) cycle: fully oxidizes acetyl-CoA, produces e– carriers (NADH, QH2)
● Occurs in mitochondrial matrix
● Net: acetyl-CoA + 3 NAD+ + Q + GDP → 2 CO2 + 3 NADH + QH2 + GTP
○ Requires oxygen to proceed: w/o oxygen, NADH accumulates from e– transport chain (ETC), stalls cycle
● Steps
○ Acetyl-CoA + oxaloacetate + H2O ⤚(citrate synthase)→ citrate + CoASH + H+
■ ΔG ≪ 0: irreversible rxn., drives cycle forward
■ Inhibited by ATP, NADH, citrate, succinyl-CoA
○ Citrate ⥫(aconitase)⥬ cis-aconitate + H2O ⥫(aconitase)⥬ isocitrate
■ Isomerizes citrate to isocitrate
■ Aconitase requires Fe2+ cofactor
○ Isocitrate + NAD+ ⥫(isocitrate DH)⥬ oxalosuccinate + NADH ⇌ α-ketoglutarate (α-KG) + CO 2 + NADH
■ 1st redox, rate-limiting step of citric acid cycle
■ Inhibited by ATP, NADH
■ Activated by ADP, NAD+
○ α-KG + CoASH + NAD+ ⤚(α-KG DH)→ succinyl-CoA + CO2 + NADH
■ Uses excess redox energy to create thioester (high-energy), irreversible
■ α-KG DH coenzymes, mechanism are same as PDH
■ Inhibited by ATP, NADH, succinyl-CoA
■ Activated by ADP, Ca2+
○ Succinyl-CoA + GDP + Pi ⥫(succinyl-CoA synthetase)⥬ succinate + GTP + CoASH
■ Spends energy stored in thioester to create GTP
■ Nucleoside diphosphate kinase eventually transfers phosphate from GTP to ATP
○ Succinate + Q ⥫(succinate DH)⥬ fumarate + QH 2
■ 2nd redox, occurs on inner membrane
■ Succinate DH: flavoprotein, bonded to e– acceptor FAD
● Complex II in ETC
○ Fumarate + H2O ⥫(fumarase)⥬ malate
○ Malate + NAD+ ⥫(malate DH)⥬ oxaloacetate + NADH
■ 3rd redox
■ Regenerates oxaloacetate
● Where did oxaloacetate C’s go?
○ Carbonyl C became one of the backbone C’s
○ CH2 C became one of the CAs
○ 2 CA’s were lost as CO2
● Where did acetyl-CoA C’s go?
○ CH3 C became one of the backbone C’s
○ Thioester C became one of the CAs
● Net results of aerobic respiration
○ Metabolic steps
■ Glycolysis: glucose + 2 NAD+ + 2 ADP → 2 pyruvate + 2 NADH + 2 ATP
■ PDH: 2× (pyruvate + CoASH + NAD+ → acetyl-CoA + CO2 + NADH)
■ Citric acid cycle: 2× (acetyl-CoA + 3 NAD+ + Q + GDP → 2 CO2 + CoASH + 3 NADH + QH2 + GTP)
○ ATP yield
■ 1 GTP = 1 ATP
■ 1 NADH ≈ 2.5 ATP, on average
■ 1 QH2 ≈ 1.5 ATP
■ Each glucose yields 30–32 ATP aerobically
10.3. Electron Transport Chain
● Redox to get from NAD+/NADH (lowest red. potential) to O2/H2O (highest red. potential)
● Proton-motive force (PMF): electrochemical gradient
○ Stores energy, couples e– transport (exergonic) to oxidative phosphorylation (endergonic)
○ Intermembrane space: high [H+], (+)-charged, low pH
○ Matrix: low [H+], (–)-charged, high pH
● Occurs across mitochondrial cristae of inner membrane
● e– carriers: NAD+/NADH, FMN/FMNH2, succinate/fumarate, FAD/FADH2, ubiquinone/ubiquinol (Q/QH2), FeSox/red, cyt cox/red,
O2/H2O
● Steps
○ Complex I: NADH:Q oxidoreductase
■ Net: NADH + Q + 5 H+in ⇌ NAD+ + QH2 + 4 H+out
■ Shuttles 2 e– from NADH to FMN to FeS clusters to Q
○ Complex II: succinate:Q oxidoreductase, a.k.a. succinate DH
■ Net: succinate + Q ⇌ fumarate + QH2
■ Shuttles 2 e– from succinate to FAD to FeS cluster to Q
■ No coupled H+ transport, b/c red. potentials of succinate/fumarate, Q/QH2 are similar
○ Complex III: Q:cyt c oxidoreductase
■ Net: QH2 + 2 cyt cox + 2 H+in ⇌ Q + 2 cyt cred + 4 H+out
■ Shuttles 2 e– from QH2 to FeS cluster to 2 cyt cox
■ Q cycle
● QH2 + Q + cyt cox ⇌ Q + Q• + cyt cred + 2 H+out
○ QH2 pumps 2 H+ out, gives 1 e– each to cyt cox and Q
● QH2 + Q• + cyt cox + 2 H+in ⇌ Q + QH2 + cyt cred + 2 H+out
○ QH2 pumps 2 H+ out, gives 1 e– each to cyt cox and Q• (semiquinone)
○ Complex IV: cyt c oxidase
■ Net: 2 cyt cred + ½ O2 + 4 H+in ⇌ 2 cyt cox + H2O + 2 H+out
■ Shuttles 2 e– from 2 cyt cred to cyt oxidase to ½ O2 (final e– acceptor)
● NADH shuttles: NADH from glycolysis can’t enter mitochondria
○ Glycerol 3-P shuttle: converts NADH to QH2, 1.5 ATP per NADH
■ Glycerol 3-P can enter mitochondria
● Cytosol: DHAP + NADH ⥫(GPDH-C)⥬ glycerol 3-P + NAD+
● Outer side of inner mitochondrial membrane: glycerol 3-P + Q ⥫(GPDH-M) ⥬ DHAP + QH 2
○ Malate–Asp shuttle
■ Convert oxaloacetate into malate, which can cross mitochondria
● Cytosol: oxaloacetate + NADH ⥫(malate DH)⥬ malate + NAD +
● Matrix: malate + NAD+ ⥫(malate DH)⥬ oxaloacetate + NADH
■ Regenerate oxaloacetate from Asp, which can cross mitochondria
● Matrix: oxaloacetate + Glu ⥫(Asp transaminase)⥬ Asp + α-KG
● Cytosol: Asp + α-KG ⥫(Asp transaminase)⥬ oxaloacetate + Glu

10.4. Oxidative Phosphorylation


● Releases energy stored in electrochemical gradient for ATP synthesis
● Chemiosmotic coupling: PMF → mechanical energy → chemical energy
● ATP synthase: reduces oxygen in the final step of the electron transport chain in order to utilize the proton gradient and generate
ATP
○ FO region: ion channel for H+, w/in inner mitochondrial membrane (hydrophobic)
■ c subunits: 10 H+ needed to turn rotor in humans
○ F1 region: catalyzes ADP + Pi ⇌ ATP, protrudes into matrix (hydrophilic)
■ α/β hexamer: fits 3 ADP, each c10 turn catalyzes 1 ATP synthesis
● Respiratory control: regulates ox. phos.
○ Abundant oxygen: rate of ox. phos. depends on [ADP]
■ ADP activates isocitrate DH → faster citric acid cycle → [NADH], [QH2] ↑ → faster ETC
○ Limited oxygen: slower ox. phos.
■ Slower ETC → [NADH], [QH2] ↓ → citric acid cycle inhibited

11. Lipid, Amino Acid Metabolism


11.1. Lipid Digestion, Absorption
● Digestion
○ Dietary fat: mostly triacylglycerols (TGLs), some cholesterols/cholesteryl esters/phospholipids/free FAs
○ Emulsified in duodenum w/ water, bile (secreted by liver)
■ Small fat clusters, SA ↑
○ Hydrolyzed into 2-monoacylglycerols, free FAs, cholesterols
■ By pancreatic lipase, colipase, cholesterol esterase (secreted by lipase)
● Micelle formation
○ 2-monoacylglycerols, free FAs, cholesterols, bile salts form micelles
○ Bile salts are reabsorbed at end of ileum
○ Remaining fats are indigestible, excreted
● Adsorption
○ Micelles adsorb into brush border of intestinal mucosa
○ Lipids re-esterify into TGLs/cholesteryl esters
○ Packaged into chylomicrons w/ apoproteins, fat-soluble vitamins, other lipids
○ Exported into lymphatic system thru lacteals, enter bloodstream thru thoracic duct
■ Short-chain FAs are more water-soluble, just diffuse into bloodstream
11.2. Lipid Mobilization
● Hormone-sensitive lipase (HSL) in adipose: hydrolyzes TGLs into glycerol, free FAs
○ Activated by insulin ↓, cortisol, Epi
● Lipoprotein lipase (LPL) in liver: metabolizes chylomicrons, very-low-density lipoproteins (VLDLs)
11.3. Lipid Transport
● Lipoproteins: apolipoproteins + lipids, allow hydrophobic FAs to be transported thru bloodstream
● Lipoprotein density: protein:lipid ratio
○ Chylomicrons: deliver digested TGLs, cholesteryl esters from intestine to cells
■ Very water-soluble, built in intestinal lining
○ Very-low-density (VLDLs): deliver TGLs, cholesterols, FAs from liver to cells
■ Built in liver
○ Intermediate-density (IDLs)/VLDL remnants: VLDLs that have deposited TGLs in adipose
■ Some are reabsorbed by liver
■ Some pick up HDL cholesteryl esters to form LDLs
○ Low-density (LDLs): deliver cholesterol to cells
■ Cholesterol: used for biosynthesis, plasma membranes, bile acid/salt synthesis, steroidogenesis
■ “Bad” cholesterol, for carrying cholesterol
○ High-density (HDLs): collect excess cholesterol in blood (cholesterol recovery)
■ Also deliver cholesterol to steroidogenic cells
■ Also transfer apolipoproteins to other lipoproteins
■ Built in liver, intestines
■ “Good” cholesterol, for recovering cholesterol for excretion
● Apolipoproteins: receptor proteins in lipoproteins, used for signaling
○ apoA-I: activates lecithin–cholesterol acyltransferase (LCAT), which catalyzes cholesterol esterification
○ Apolipoproteins B: primary apolipoprotein
■ apoB-48: mediates chylomicron secretion
■ apoB-100: allows LDL uptake by liver
○ apoC-II: activates LPL
○ apoE: allows chylomicron remnant/VLDL uptake by liver
11.4. Cholesterol Metabolism
● Cholesterol sources
○ LDL, HDL
○ Biosynthesis in liver
■ Citrate shuttle exports mitochondrial acetyl-CoA into cytoplasm
■ 2 acetyl-CoA ⥫(thiolase)⥬ acetoacetyl-CoA + CoASH
● Claisen condensation: enolized thioester attacks carbonyl of another thioester
■ Acetoacetyl-CoA + acetyl-CoA ⥫(HMG-CoA synthase)⥬ 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) +
CoASH
■ HMG-CoA + 2 NADPH ⤚(HMG-CoA reductase)→ mevalonate + 2 NADP +
● HMG-CoA reductase aids in the production of cholesterol in the smooth ER
● Rate-limiting step, occurs in smooth ER
● NADPH comes from PPP
■ Mevalonate → … → cholesterol, w/ NADPH as reducing agent
● Activated by insulin
● Inhibited by cholesterol
● Lecithin–cholesterol acyltransferase (LCAT): adds FA to cholesterol to produce cholesteryl ester (water-soluble)
○ Found in bloodstream
○ Activated by HDL apoproteins
● Cholesteryl ester transfer protein (CETP): transfers cholesteryl esters from HDL to IDL, forming LDL
11.5. Fatty Acids, Triacylglycerols
● Naming
○ (# C’s):(# double bonds)
○ ω numbering system: position of last double bond, counted from end
● Saturated: no double bonds
○ Palmitic acid (16:0): only FA that can be biosynthesized de novo in humans
● Unsaturated: double bonds
○ Most unsaturated FAs can’t be biosynthesized in humans, must come from diet
■ Most natural unsaturated FAs are cis
■ Trans fats are unsaturated but solids at room temp, membrane fluidity ↓
○ Linoleic acid: ω-6 FA (18:2 cis-9,12)
○ α-linoleic acid: ω-3 FA (18:3 cis-9,12,15)
● De novo FA synthesis: creates palmitic acid (16:0) from acetyl-CoA
○ Nontemplate synthesis: no nucleic template needed
○ Occurs mostly in liver (and some in fat)
○ Activated by insulin after high-carb meal
○ Steps
■ PDH produces acetyl-CoA from pyruvate in matrix
■ Citrate shuttle exports mitochondrial acetyl-CoA to cytoplasm
● Citrate synthase converts acetyl-CoA + oxaloacetate to citrate
● Citrate lyase reverts citrate to oxaloacetate + acetyl-CoA
● Oxaloacetate returns to mitochondria
■ Acetyl-CoA + bicarbonate + ATP ⤚(acetyl-CoA carboxylase (ACC))→ malonyl-CoA + ADP
● Rate-limiting step, biotin cofactor
● Malonyl-CoA: –OOC–CH2–C(O)SCoA
■ FA synthase/palmitate synthase
● Activate growing chain, malonyl-CoA w/ acyl carrier protein (ACP)
○ Requires pantothenate (vit. B5) cofactor
● ⦚–C–C(O)S–ACP + malonyl-ACP → ⦚–C–C(O)–C–C(O)S–ACP + CO2 + ACP–SH
○ Condensation: deprotonate α-C of malonyl-ACP (1,3-dicarbonyl), Nuc attacks carbonyl of FA chain
● ⦚–C–C(O)–C–C(O)S–ACP + NADPH ⇌ ⦚–C–C(OH)–C–C(O)S–ACP + NADP+
○ Reduce β-carbonyl to hydroxyl
● ⦚–C–C(OH)–C–C(O)S–ACP ⇌ ⦚–C–C=C–C(O)S–ACP + H2O
○ Dehydrate hydroxyl
● ⦚–C–C=C–C(O)S–ACP + NADPH → ⦚–C–C–C–C(O)S–ACP + NADP+
○ Reduce alkene to alkane
● Repeat 8 times
■ Some elongation/desaturation in SER
● Triacylglycerol synthesis: attaches 3 FA-CoA’s to glycerol
○ Occurs mostly in liver (and some in fat)
○ Packaged as VLDLs
● β-oxidation
○ Occurs in mitochondria (< 20 C’s), peroxisomes (> 20 C’s)
■ Long-chain FAs (LCFAs, 14–20 C’s) need carnitine shuttle to enter mitochondria
● Acyl-CoA can’t enter mitochondria, but acyl-carnitine can
● Rate-limiting step of β-oxidation
○ Activated by glucagon, inhibited by insulin
○ Steps
■ Activation: FA + CoASH + ATP ⤚(FA-CoA synthetase)→ FA-CoA + AMP + PP i
● Occurs in cytoplasm, traps FA in cell
■ ⥫–C–C–C–C(O)SCoA + Q ⥬(acyl-CoA DH)⥬ ⦚–C–C=C–C(O)SCoA + QH2
● Oxidize α-β alkane to alkene
■ ⦚–C–C=C–C(O)SCoA + H2O ⥫(enoyl-CoA hydratase)⥬–C–C(OH)–C–C(O)SCoA
● Hydrate alkene at β-C
■ ⦚–C–C(OH)–C–C(O)SCoA + NAD+ ⥫(hydroxyacyl-CoA DH)⥬ ⦚–C–C(O)–C–C(O)SCoA + NADH
● Oxidize hydroxyl to carbonyl
■ ⤚ –C–C(O)–C–C(O)SCoA + CoASH ⤚ (thiolase)→ ⦚–C–C(O)SCoA + acetyl-CoA
● Split β-keto acid
○ Each 2 C’s yield 1 QH2, 1 NADH
○ β-oxidizing odd-numbered FAs
■ Carboxylate the remaining propionyl-CoA
● Requires biotin (vit. B7) cofactor
■ Isomerize methylmalonyl-CoA into succinyl-CoA
● Requires cobalamin (vit. B12) cofactor
○ Pernicious anemia: B12 deficiency6
■ Succinyl-CoA enters citric acid cycle or gluconeogenesis
○ β-oxidizing unsaturated FAs
■ Double bond at odd-numbered C: just isomerize to move double bond
● cis 3,4 → trans 2,3
● Yields only NADH (no QH2 produced)
■ Double bond at even-numbered C: oxidize to yield QH2, reduce conjugated double bonds using NADPH, then
isomerize to move double bond
● cis 2,3 + cis 4,5 → trans 3,4 → trans 2,3
● Yields QH2 and NADH, but costs NADPH
11.6. Ketone Bodies
● Ketone bodies: acetoacetate, β-hydroxybutyrate
● Metabolism
○ Cardiac/skeletal muscle, renal cortex revert ketone bodies to acetyl-CoA
○ Most energy source for brain during prolonged fasting
■ Ketone body metabolism → acetyl-CoA inhibits PDH → glycolysis, glucose uptake ↓ in brain
■ Conserves proteins, prevents gluconeogenesis from AAs
● Ketogenesis
○ Occurs in liver mitochondria due to acetyl-CoA buildup (from β-oxidation of fats) in fasting
○ 3 acetyl-CoA ⥫(thiolase, HMG-CoA synthase)⥬ HMG-CoA + 2 CoASH
○ HMG-CoA ⥫(HMG-CoA lyase)⥬ acetoacetate + acetyl-CoA
○ Reduce acetoacetate to β-hydroxybutyrate using NADH
○ Acetoacetate → acetone + CO2
■ Non-enzymatic rxn., acetone cannot be metabolized
● Ketolysis
○ Re-oxidize β-hydroxybutyrate to acetoacetate using NAD+
○ Activation: acetoacetate + succinyl-CoA ⥫(thiophorase) ⥬ acetoacetyl-CoA + succinate
○ Split acetoacetyl-CoA into 2 acetyl-CoA
11.7. Protein Catabolism
● Last resort: muscle (esp. cardiac) is essential to survival
● Proteolysis from diet
○ Stomach protease: pepsin
○ Pancreatic proteases: trypsin, chymotrypsin, carboxypeptidases A/B
○ Small intestinal brush-border enzymes: dipeptidase, aminopeptidase
● Transamination: AA + KA ⇌ KA + AA
○ Requires PLP (vit. B6) cofactor, which stabilizes intermediate carbanion
○ Pairs: Ala/pyruvate, Asp/oxaloacetate, Glu/α-KG, etc.
● Deamination: KA ⇌ AA + NH3
● Urea cycle
○ Most cells waste N as Glu (most transamination)
○ Muscles waste N as Ala
○ Deamination wastes N as NH3
○ Liver wastes N as urea: CO(NH2)2
● Glucogenic AAs: can feed into gluconeogenesis
○ All except L’s (Leu, Lys)
● Ketogenic AAs: can be converted into acetyl-CoA, ketone bodies
○ “LFIT”: Leu, Lys, Phe, Iso, Thr, Tyr, Trp

12. Metabolism Bioenergetics, Regulation


12.1. Thermodynamics, Bioenergetics
● Systemic: open system
● Sub/cellular: closed system
● ΔU = Q – W, where U = internal energy, Q = heat
● ΔG = ΔH – TΔS
○ At constant pressure and volume, ΔU = ΔH = Q
● ΔG° = –RT ln K, where K = equilibrium constant
○ ΔG = ΔG° + RT ln Q, where Q = rxn. quotient
■ Standard conds. (ΔG°): 1 M, 1 atm, 25 °C
■ Modified standard state (ΔG°′): standard conds., and pH 7
● ΔGcell° = –nFEcell°, where n = mol e– transferred, F = Faraday constant, Ecell° = EC cell’s standard reduction potential
12.2. ATP
● Major energy carrier
○ Mid-level (ΔG°′ ≈ –30.5 kJ/mol): enough energy to power processes, while minimizing waste
○ Production: AMP/ADP/ATP
■ Substrate-level phosphorylation: directly phosphorylate ADP using coupled rxn.
■ Oxidative phosphorylation (ox. phos.): power ATP synthase using PMF from ETC
○ Stores energy in phosphate bonds: (–)-charged, mutual repulsion
○ Releases energy thru hydrolysis (breaking bonds is still endothermic)
● Coupling: fuels energetically unfavorable rxns. w/ ATP hydrolysis
● Phosphoryl group transfer: in/activate a molecule by transferring high-energy phosphate
12.3. Redox
● Half-rxns.: split redox rxns. into reduction (gain e–), oxidation (lose e–) components
● Spontaneous redox: ΔG < 0 (free energy), E > 0 (electromotive force)
● High-energy e– carriers
○ NADH, NADPH, FADH2, FMNH2, QH2, cyt cred, glutathione, etc.
○ Flavoproteins: contain riboflavin (vit. B2) cofactor
■ Flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN)
■ e– carriers in mitochondria/chloroplasts
■ Activate B vitamins
■ Coenzymes for β-oxidation, PDH, glutathione reduction
12.4. Metabolic States
● Homeostasis: maintain a physiologically stable state using energy
○ Not equilibrium! Equilibrium = death
● Postprandial/absorptive/well-fed state: abundant nutrients, lasts 3–5 hrs after meal
○ Anabolism, fuel storage > catabolism
○ Nutrients move from gut to liver (thru hepatic portal vein) to tissue
○ Blood sugar ↑ → insulin ↑
■ Tissues: glucose uptake
■ Liver: glycogenesis, then FA synthesis
● In this state, liver subsist mostly on excess AA metabolism
■ Fat: triacylglycerol synthesis
■ Muscle: protein synthesis
■ Nervous tissue, RBCs unaffected
● Nervous tissue subsists solely on aerobic respiration (or ketone bodies in prolonged fasting state)
● RBCs subsist solely on anaerobic glycolysis
● Postabsorptive/fasting state
○ Counterregulatory hormones (glucagon, cortisol, Epi, NE, growth hormone): oppose insulin
■ Liver: releases glucose, glycogenolysis (and some gluconeogenesis)
■ Fat: releases FAs (for acetyl-CoA)
■ Skeletal muscle: releases AAs (for gluconeogenesis)
● Prolonged fasting state/starvation
○ Use ketone bodies, not glucose, as major energy source
■ Avoid metabolizing AAs for gluconeogenesis
○ High glucagon, Epi
■ Liver: rapid glycogenolysis
■ Fat: rapid lipolysis (for ketone bodies)
■ Muscle: switches to burning FAs, slow AA breakdown (for gluconeogenesis for brain, RBCs)
■ Brain: switches to using ketone bodies (and some glucose)
■ RBCs must still use glucose
12.5. Hormonal Regulation of Metabolism
● Systemic regulation: thru covalent mechanisms (de/phosphorylation)
○ Peptides: rapid adjustments thru 2nd-messenger cascades (e.g., insulin)
○ AAs, steroids: long-range adjustments thru transcriptional control (e.g., thyroid hormones, cortisol)
● Insulin: well-fed, Glc uptake ↑, carb metabolism ↑, storage ↑
○ Peptide, secreted by pancreatic β cells (in Langerhans islets)
○ Controlled mainly by blood sugar
■ Glc metabolism → [ATP] ↑ in β cells → Ca 2+ release → insulin exocytosis
● Insulin secretion ∝ [blood sugar] when [blood sugar] > 100 mg/dL (~5.6 mM)
■ Also affected by glucagon, somatostatin
○ Need insulin for effective Glc uptake: resting skeletal muscle, fat
■ Store glucose if [Glc] is high
○ Don’t need insulin: nervous tissue, kidney tubules, intestinal mucosa, RBCs, pancreatic β cells
■ Absorb Glc even if [Glc] is low
○ Increases…
■ Glc uptake, carb metabolism in muscle, fat
■ Glycogenesis in liver, muscle (glucokinase, glycogen synthase ↑)
■ Glc, triacylglycerol uptake in fat
■ LPL activity (clears chylomicrons/VLDLs from blood)
■ Lipogenesis in liver, fat
○ Decreases…
■ Glycogenolysis in liver, muscle (glycogen phosphorylase, G6Pase ↓)
■ Lipolysis in fat
■ Ketone body synthesis in liver
● Glucagon: fasting, gluconeogenesis ↑, ketogenesis/FA metabolism ↑, storage ↓
○ Peptide, secreted by pancreatic α cells (in Langerhans islets)
○ Increases…
■ Glycogenolysis in liver (glycogen phosphorylase ↑, glycogen synthase ↓)
■ Gluconeogenesis in liver (PC, PEPCK, F1,6BPase ↑)
■ Ketogenesis in liver
■ Lipolysis in liver (HSL ↑)
○ Decreases…
■ Lipogenesis in liver
● Glucocorticoids: “fight or flight,” blood sugar ↑, Glc uptake ↓, storage ↓
○ Steroids, secreted by adr. cortex in stress (e.g., cortisol)
○ Increases…
■ Gluconeogenesis, AA breakdown in liver
■ Lipolysis in fat
■ Glucagon, Epi, other catecholamines
○ Decreases…
■ Glc uptake in muscle, fat, lymphoid tissue (reserves Glc for nervous tissue)
○ Long term: hyperglycemia → insulin ↑, fat storage ↑
● Catecholamines: “adrenaline rush”
○ AAs, secreted by adr. medulla (e.g., Epi/adrenaline, NE/noradrenaline)
○ Increases…
■ Glycogenolysis in liver, muscle (glycogen phosphorylase ↑)
● In skeletal muscles, resulting G6P is metabolized, not released into bloodstream (no G6Pase)
■ Lipolysis in fat (HSL ↑)
■ Basal metabolic rate (BMR) thru sympathetic responses
● Thyroid hormones: permissive (more or less constant)
○ AAs, secreted by thyroid (e.g., thyroxine/T4, triiodothyronine/T3)
■ T4 ⤚(deiodinases)→ T3 + I–
○ Increases…
■ BMR → oxygen consumption, heat production ↑
● T3 is faster-, shorter-acting than T4
■ Glc absorption in small intestine
■ Cholesterol clearance in blood
12.6. Tissue-Specific Metabolism
● Liver: maintains constant blood sugar, synthesizes ketone bodies in excess β-oxidation
○ Well-fed: subsists on excess AAs
■ Glycogenesis, FA synthesis (released as VLDLs)
○ Fasting: subsists on FAs
■ Glycogenolysis, gluconeogenesis (from lactate, glycerol, AAs)
● Fat: stores triacylglycerols
○ Well-fed: subsists on Glc
■ Release FAs from chylomicrons/VLDLs (LPL ↑), triacylglycerol synthesis
○ Fasting: subsists on FAs
■ Release FAs (HSL ↑)
● Skeletal muscle: major fuel consumer
○ Resting
■ Well-fed: subsists on Glc, FAs
● Glc uptake, glycogenesis, protein synthesis
■ Fasting: subsists on free FAs
■ Prolonged fasting: subsists on ketone bodies
○ Active
■ Very short term (2–7 s): subsists on creatine phosphate
■ Short term: subsists on anaerobic glycolysis of glycogen stores, blood sugar, free FAs
■ Long term (1–3 hrs): glycogen depleted, subsists on FAs
● Cardiac muscle
○ Well-fed, fasting: subsists on FAs
○ Prolonged fasting: subsists on ketone bodies
○ Failing heart: subsists more on Glc (anaerobic)
● Brain
○ Well-fed, fasting: needs continuous supply of Glc
■ FAs cannot cross blood–brain barrier
■ Hypoglycemia (< 70 mg/dL) → glucagon, Epi ↑
○ Prolonged fasting: subsists on ⅔ ketone bodies, ⅓ Glc
12.7. Integrative Metabolism
● Measuring metabolism
○ Measure blood sugar, thyroid hormones/TSH, insulin/glucagon, oxygen/CO2
○ Respirometry: measures respiratory quotient (RQ)
■ RQ = (CO2 produced)/(O2 consumed) for complete combustion of a fuel
● RQ ≈ 1 (carbs), 0.7 (lipids)
■ Resting RQ ≈ 0.8, changes depending on stress, starvation, exercise
○ Calorimetry: measures basal metabolic rate (BMR, amt. energy required for 1 sedentary day)
■ Measures heat exchange using large insulated chamber w/ heat sinks
■ Estimate w/ previous data using age, weight, height, gender
● Body mass regulation
○ Water: frequent, minor fluctuations in mass
○ Lipids: most responsible for gradual change in mass
○ Body mass ↑ → BMR ↑
■ Small changes in intake → offset w/ small changes in energy expenditure
■ Small changes in activity → offset w/ small changes in hunger
○ Ghrelin (hunger ↑), orexin (appetite ↑), leptin (orexin ↓ → appetite ↓)
○ Body mass index: BMI = (mass in kg)/(height in m)2
■ Underweight: < 18.5
■ Normal: 18.5–25
■ Overweight: 25–30
■ Obese: > 30

You might also like